<SEC-DOCUMENT>0000939767-23-000047.txt : 20230509
<SEC-HEADER>0000939767-23-000047.hdr.sgml : 20230509
<ACCEPTANCE-DATETIME>20230509161314
ACCESSION NUMBER:		0000939767-23-000047
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20230509
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230509
DATE AS OF CHANGE:		20230509

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			EXELIXIS, INC.
		CENTRAL INDEX KEY:			0000939767
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				043257395
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-30235
		FILM NUMBER:		23902153

	BUSINESS ADDRESS:	
		STREET 1:		1851 HARBOR BAY PARKWAY
		CITY:			ALAMEDA
		STATE:			CA
		ZIP:			94502
		BUSINESS PHONE:		6508377000

	MAIL ADDRESS:	
		STREET 1:		1851 HARBOR BAY PARKWAY
		CITY:			ALAMEDA
		STATE:			CA
		ZIP:			94502

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EXELIXIS INC
		DATE OF NAME CHANGE:	20000207

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EXELIXIS PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	20000106
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>exel-20230509.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:897e643e-4be9-4b6f-aa4e-b65e51dbad21,g:fe04d92b-85f9-48b7-ab16-4989ee371866,d:3ae763590f6f4a6f957c5f00562ea37a--><html xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>exel-20230509</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i17e417b11a954ed38a4e548f5772d460_D20230509-20230509" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjNhZTc2MzU5MGY2ZjRhNmY5NTdjNWYwMDU2MmVhMzdhL3NlYzozYWU3NjM1OTBmNmY0YTZmOTU3YzVmMDA1NjJlYTM3YV80L2ZyYWc6ZTU3MWQyYTEwZDFkNDdlMzgzMGU2YjljNTYzYjllNjYvdGFibGU6YzE1NTM3YThlMTk2NDMxYTgxYzYzNzI4ZGViN2Y5Y2IvdGFibGVyYW5nZTpjMTU1MzdhOGUxOTY0MzFhODFjNjM3MjhkZWI3ZjljYl8yLTEtMS0xLTExMDk0MQ_d882c735-b4c6-4243-9eb5-eecccfafd49c">0000939767</ix:nonNumeric><ix:nonNumeric contextRef="i17e417b11a954ed38a4e548f5772d460_D20230509-20230509" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjNhZTc2MzU5MGY2ZjRhNmY5NTdjNWYwMDU2MmVhMzdhL3NlYzozYWU3NjM1OTBmNmY0YTZmOTU3YzVmMDA1NjJlYTM3YV80L2ZyYWc6ZTU3MWQyYTEwZDFkNDdlMzgzMGU2YjljNTYzYjllNjYvdGFibGU6YzE1NTM3YThlMTk2NDMxYTgxYzYzNzI4ZGViN2Y5Y2IvdGFibGVyYW5nZTpjMTU1MzdhOGUxOTY0MzFhODFjNjM3MjhkZWI3ZjljYl81LTEtMS0xLTExMDk0MQ_ddc3966d-1ca6-4b05-b915-79e7a9039722">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="exel-20230509.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i17e417b11a954ed38a4e548f5772d460_D20230509-20230509"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000939767</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-09</xbrli:startDate><xbrli:endDate>2023-05-09</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i3ae763590f6f4a6f957c5f00562ea37a_1"></div><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:199.50pt"><tr><td style="width:1.0pt"></td><td style="width:97.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:97.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:20pt"><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:16pt;font-weight:700;line-height:100%">FORM</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:16pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i17e417b11a954ed38a4e548f5772d460_D20230509-20230509" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjNhZTc2MzU5MGY2ZjRhNmY5NTdjNWYwMDU2MmVhMzdhL3NlYzozYWU3NjM1OTBmNmY0YTZmOTU3YzVmMDA1NjJlYTM3YV8xL2ZyYWc6NWU0MGI3MjMyOTVmNDhlYWIxZGY1M2ExMzZhMmVlNWEvdGFibGU6NzRkYzE2MmQxYTk0NGVhMWI5MmFjYjQ4NDE3N2YzMTIvdGFibGVyYW5nZTo3NGRjMTYyZDFhOTQ0ZWExYjkyYWNiNDg0MTc3ZjMxMl8wLTEtMS0xLTExMDk0MQ_a1eadae9-6c1f-4542-8262-8109dc8b0c96">8-K</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CURRENT REPORT </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 13 OR 15(d) OF THE </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES EXCHANGE ACT OF 1934 </span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="i17e417b11a954ed38a4e548f5772d460_D20230509-20230509" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjNhZTc2MzU5MGY2ZjRhNmY5NTdjNWYwMDU2MmVhMzdhL3NlYzozYWU3NjM1OTBmNmY0YTZmOTU3YzVmMDA1NjJlYTM3YV8xL2ZyYWc6NWU0MGI3MjMyOTVmNDhlYWIxZGY1M2ExMzZhMmVlNWEvdGV4dHJlZ2lvbjo1ZTQwYjcyMzI5NWY0OGVhYjFkZjUzYTEzNmEyZWU1YV8yMjA_9cae6a51-7773-4a59-8490-10b56bbffaac">May 9, 2023</ix:nonNumeric></span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:200.25pt"><tr><td style="width:1.0pt"></td><td style="width:198.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:47pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"><div style="text-align:center"><img src="exel-20230509_g1.jpg" alt="Exelixis_Logo_RGB_2023.jpg" style="height:47px;margin-bottom:5pt;vertical-align:text-bottom;width:177px"/></div></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:16pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i17e417b11a954ed38a4e548f5772d460_D20230509-20230509" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjNhZTc2MzU5MGY2ZjRhNmY5NTdjNWYwMDU2MmVhMzdhL3NlYzozYWU3NjM1OTBmNmY0YTZmOTU3YzVmMDA1NjJlYTM3YV8xL2ZyYWc6NWU0MGI3MjMyOTVmNDhlYWIxZGY1M2ExMzZhMmVlNWEvdGFibGU6N2E2YTkwZjI0ODFhNDJjOWEyNTEyYjk2YTQ1NjM2ODIvdGFibGVyYW5nZTo3YTZhOTBmMjQ4MWE0MmM5YTI1MTJiOTZhNDU2MzY4Ml8xLTAtMS0xLTExMDk0MQ_b7c1378e-8833-43fa-9c7a-75a03292de27">EXELIXIS, INC.</ix:nonNumeric></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Exact name of registrant as specified in its charter)</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.619%"><tr><td style="width:1.0%"></td><td style="width:38.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.174%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.145%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i17e417b11a954ed38a4e548f5772d460_D20230509-20230509" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjNhZTc2MzU5MGY2ZjRhNmY5NTdjNWYwMDU2MmVhMzdhL3NlYzozYWU3NjM1OTBmNmY0YTZmOTU3YzVmMDA1NjJlYTM3YV8xL2ZyYWc6NWU0MGI3MjMyOTVmNDhlYWIxZGY1M2ExMzZhMmVlNWEvdGFibGU6MGQ1MjE5OTExNDlhNDJhZTk5YmRiNTkzNGIwM2ZjOTAvdGFibGVyYW5nZTowZDUyMTk5MTE0OWE0MmFlOTliZGI1OTM0YjAzZmM5MF8wLTAtMS0xLTExMDk0MQ_a8d60ba3-49d3-474a-8293-7cf07dcf9743">Delaware</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i17e417b11a954ed38a4e548f5772d460_D20230509-20230509" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjNhZTc2MzU5MGY2ZjRhNmY5NTdjNWYwMDU2MmVhMzdhL3NlYzozYWU3NjM1OTBmNmY0YTZmOTU3YzVmMDA1NjJlYTM3YV8xL2ZyYWc6NWU0MGI3MjMyOTVmNDhlYWIxZGY1M2ExMzZhMmVlNWEvdGFibGU6MGQ1MjE5OTExNDlhNDJhZTk5YmRiNTkzNGIwM2ZjOTAvdGFibGVyYW5nZTowZDUyMTk5MTE0OWE0MmFlOTliZGI1OTM0YjAzZmM5MF8wLTEtMS0xLTExMDk0MQ_09879d9b-3685-462b-a4c7-fcef8dd8b28b">000-30235</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i17e417b11a954ed38a4e548f5772d460_D20230509-20230509" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjNhZTc2MzU5MGY2ZjRhNmY5NTdjNWYwMDU2MmVhMzdhL3NlYzozYWU3NjM1OTBmNmY0YTZmOTU3YzVmMDA1NjJlYTM3YV8xL2ZyYWc6NWU0MGI3MjMyOTVmNDhlYWIxZGY1M2ExMzZhMmVlNWEvdGFibGU6MGQ1MjE5OTExNDlhNDJhZTk5YmRiNTkzNGIwM2ZjOTAvdGFibGVyYW5nZTowZDUyMTk5MTE0OWE0MmFlOTliZGI1OTM0YjAzZmM5MF8wLTItMS0xLTExMDk0MQ_c9346528-1905-4def-9a5f-236695fe0789">04-3257395</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(State or Other Jurisdiction of Incorporation)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Commission File Number)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(IRS Employer Identification No.)</span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i17e417b11a954ed38a4e548f5772d460_D20230509-20230509" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjNhZTc2MzU5MGY2ZjRhNmY5NTdjNWYwMDU2MmVhMzdhL3NlYzozYWU3NjM1OTBmNmY0YTZmOTU3YzVmMDA1NjJlYTM3YV8xL2ZyYWc6NWU0MGI3MjMyOTVmNDhlYWIxZGY1M2ExMzZhMmVlNWEvdGV4dHJlZ2lvbjo1ZTQwYjcyMzI5NWY0OGVhYjFkZjUzYTEzNmEyZWU1YV8xNTk2_a3932620-4732-443a-85e8-66c095025e0d">1851 Harbor Bay Parkway</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i17e417b11a954ed38a4e548f5772d460_D20230509-20230509" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjNhZTc2MzU5MGY2ZjRhNmY5NTdjNWYwMDU2MmVhMzdhL3NlYzozYWU3NjM1OTBmNmY0YTZmOTU3YzVmMDA1NjJlYTM3YV8xL2ZyYWc6NWU0MGI3MjMyOTVmNDhlYWIxZGY1M2ExMzZhMmVlNWEvdGV4dHJlZ2lvbjo1ZTQwYjcyMzI5NWY0OGVhYjFkZjUzYTEzNmEyZWU1YV8xNTk3_bfd61836-9467-4e23-af65-3f5c773b7747">Alameda</ix:nonNumeric>, <ix:nonNumeric contextRef="i17e417b11a954ed38a4e548f5772d460_D20230509-20230509" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjNhZTc2MzU5MGY2ZjRhNmY5NTdjNWYwMDU2MmVhMzdhL3NlYzozYWU3NjM1OTBmNmY0YTZmOTU3YzVmMDA1NjJlYTM3YV8xL2ZyYWc6NWU0MGI3MjMyOTVmNDhlYWIxZGY1M2ExMzZhMmVlNWEvdGV4dHJlZ2lvbjo1ZTQwYjcyMzI5NWY0OGVhYjFkZjUzYTEzNmEyZWU1YV8xNTk4_e8cd1e3a-f4a0-4861-ab97-493bda1eb776">California</ix:nonNumeric> <ix:nonNumeric contextRef="i17e417b11a954ed38a4e548f5772d460_D20230509-20230509" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjNhZTc2MzU5MGY2ZjRhNmY5NTdjNWYwMDU2MmVhMzdhL3NlYzozYWU3NjM1OTBmNmY0YTZmOTU3YzVmMDA1NjJlYTM3YV8xL2ZyYWc6NWU0MGI3MjMyOTVmNDhlYWIxZGY1M2ExMzZhMmVlNWEvdGV4dHJlZ2lvbjo1ZTQwYjcyMzI5NWY0OGVhYjFkZjUzYTEzNmEyZWU1YV8xNTg5_2c749563-a8e9-4f73-af98-576d96688a93">94502</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Address of principal executive offices) (Zip Code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i17e417b11a954ed38a4e548f5772d460_D20230509-20230509" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjNhZTc2MzU5MGY2ZjRhNmY5NTdjNWYwMDU2MmVhMzdhL3NlYzozYWU3NjM1OTBmNmY0YTZmOTU3YzVmMDA1NjJlYTM3YV8xL2ZyYWc6NWU0MGI3MjMyOTVmNDhlYWIxZGY1M2ExMzZhMmVlNWEvdGV4dHJlZ2lvbjo1ZTQwYjcyMzI5NWY0OGVhYjFkZjUzYTEzNmEyZWU1YV8xNTk5_20b960c7-8f18-4689-8cf7-986715c8127c">650</ix:nonNumeric>) <ix:nonNumeric contextRef="i17e417b11a954ed38a4e548f5772d460_D20230509-20230509" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjNhZTc2MzU5MGY2ZjRhNmY5NTdjNWYwMDU2MmVhMzdhL3NlYzozYWU3NjM1OTBmNmY0YTZmOTU3YzVmMDA1NjJlYTM3YV8xL2ZyYWc6NWU0MGI3MjMyOTVmNDhlYWIxZGY1M2ExMzZhMmVlNWEvdGV4dHJlZ2lvbjo1ZTQwYjcyMzI5NWY0OGVhYjFkZjUzYTEzNmEyZWU1YV8xNTkw_185dedb8-d4a4-4038-b751-5421ff02a534">837-7000</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code) </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): </span></div><div style="margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i17e417b11a954ed38a4e548f5772d460_D20230509-20230509" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjNhZTc2MzU5MGY2ZjRhNmY5NTdjNWYwMDU2MmVhMzdhL3NlYzozYWU3NjM1OTBmNmY0YTZmOTU3YzVmMDA1NjJlYTM3YV8xL2ZyYWc6NWU0MGI3MjMyOTVmNDhlYWIxZGY1M2ExMzZhMmVlNWEvdGV4dHJlZ2lvbjo1ZTQwYjcyMzI5NWY0OGVhYjFkZjUzYTEzNmEyZWU1YV8xNTky_d2e2313f-8a19-4ec3-800d-9db9d3f006ef">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </span></div><div style="margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i17e417b11a954ed38a4e548f5772d460_D20230509-20230509" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjNhZTc2MzU5MGY2ZjRhNmY5NTdjNWYwMDU2MmVhMzdhL3NlYzozYWU3NjM1OTBmNmY0YTZmOTU3YzVmMDA1NjJlYTM3YV8xL2ZyYWc6NWU0MGI3MjMyOTVmNDhlYWIxZGY1M2ExMzZhMmVlNWEvdGV4dHJlZ2lvbjo1ZTQwYjcyMzI5NWY0OGVhYjFkZjUzYTEzNmEyZWU1YV8xNTkz_83b11890-907c-465a-8a61-0681178f2b94">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </span></div><div style="margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i17e417b11a954ed38a4e548f5772d460_D20230509-20230509" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjNhZTc2MzU5MGY2ZjRhNmY5NTdjNWYwMDU2MmVhMzdhL3NlYzozYWU3NjM1OTBmNmY0YTZmOTU3YzVmMDA1NjJlYTM3YV8xL2ZyYWc6NWU0MGI3MjMyOTVmNDhlYWIxZGY1M2ExMzZhMmVlNWEvdGV4dHJlZ2lvbjo1ZTQwYjcyMzI5NWY0OGVhYjFkZjUzYTEzNmEyZWU1YV8xNTkx_3ea1e474-4b46-4061-9b62-d71f4ded5818">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </span></div><div style="margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i17e417b11a954ed38a4e548f5772d460_D20230509-20230509" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjNhZTc2MzU5MGY2ZjRhNmY5NTdjNWYwMDU2MmVhMzdhL3NlYzozYWU3NjM1OTBmNmY0YTZmOTU3YzVmMDA1NjJlYTM3YV8xL2ZyYWc6NWU0MGI3MjMyOTVmNDhlYWIxZGY1M2ExMzZhMmVlNWEvdGV4dHJlZ2lvbjo1ZTQwYjcyMzI5NWY0OGVhYjFkZjUzYTEzNmEyZWU1YV8xNTk0_2802638e-f089-4bec-92cc-11f4bb3800da">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </span></div><div><span><br/></span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section&#160;12(b) of the Act:</span></div><div style="margin-top:3pt;text-align:center"><span><br/></span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.553%"><tr><td style="width:1.0%"></td><td style="width:39.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.363%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 5.5pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 5.5pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i17e417b11a954ed38a4e548f5772d460_D20230509-20230509" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjNhZTc2MzU5MGY2ZjRhNmY5NTdjNWYwMDU2MmVhMzdhL3NlYzozYWU3NjM1OTBmNmY0YTZmOTU3YzVmMDA1NjJlYTM3YV8xL2ZyYWc6NWU0MGI3MjMyOTVmNDhlYWIxZGY1M2ExMzZhMmVlNWEvdGFibGU6NGQwYjE0NjkwODIzNDNhZmIzZjEwMjBiZmE0MDM0ZjgvdGFibGVyYW5nZTo0ZDBiMTQ2OTA4MjM0M2FmYjNmMTAyMGJmYTQwMzRmOF8xLTAtMS0xLTExMDk0MQ_9b57a22b-9b78-4ae8-b8ea-50049c62258b">Common Stock $.001 Par Value per Share</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i17e417b11a954ed38a4e548f5772d460_D20230509-20230509" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjNhZTc2MzU5MGY2ZjRhNmY5NTdjNWYwMDU2MmVhMzdhL3NlYzozYWU3NjM1OTBmNmY0YTZmOTU3YzVmMDA1NjJlYTM3YV8xL2ZyYWc6NWU0MGI3MjMyOTVmNDhlYWIxZGY1M2ExMzZhMmVlNWEvdGFibGU6NGQwYjE0NjkwODIzNDNhZmIzZjEwMjBiZmE0MDM0ZjgvdGFibGVyYW5nZTo0ZDBiMTQ2OTA4MjM0M2FmYjNmMTAyMGJmYTQwMzRmOF8xLTEtMS0xLTExMDk0MQ_82215a1e-ac39-436f-bb56-ed624d889220">EXEL</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i17e417b11a954ed38a4e548f5772d460_D20230509-20230509" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjNhZTc2MzU5MGY2ZjRhNmY5NTdjNWYwMDU2MmVhMzdhL3NlYzozYWU3NjM1OTBmNmY0YTZmOTU3YzVmMDA1NjJlYTM3YV8xL2ZyYWc6NWU0MGI3MjMyOTVmNDhlYWIxZGY1M2ExMzZhMmVlNWEvdGFibGU6NGQwYjE0NjkwODIzNDNhZmIzZjEwMjBiZmE0MDM0ZjgvdGFibGVyYW5nZTo0ZDBiMTQ2OTA4MjM0M2FmYjNmMTAyMGJmYTQwMzRmOF8xLTItMS0xLTExMDk0MQ_22582716-7b12-498a-a05e-99111ddd3281">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). Emerging growth company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i17e417b11a954ed38a4e548f5772d460_D20230509-20230509" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjNhZTc2MzU5MGY2ZjRhNmY5NTdjNWYwMDU2MmVhMzdhL3NlYzozYWU3NjM1OTBmNmY0YTZmOTU3YzVmMDA1NjJlYTM3YV8xL2ZyYWc6NWU0MGI3MjMyOTVmNDhlYWIxZGY1M2ExMzZhMmVlNWEvdGV4dHJlZ2lvbjo1ZTQwYjcyMzI5NWY0OGVhYjFkZjUzYTEzNmEyZWU1YV8xNTk1_20a564e4-7742-485d-93b3-2671364d6678">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i3ae763590f6f4a6f957c5f00562ea37a_7"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.02.  Results of Operations and Financial Condition.</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May&#160;9, 2023, Exelixis, Inc. (&#8220;Exelixis&#8221;) issued a press release announcing its financial results for the quarter ended March&#160;31, 2023, and providing a corporate update. A copy of such press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. </span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information in this report, including the exhibit hereto, shall not be deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained in this report and in the accompanying exhibit shall not be incorporated by reference into any filing with the U.S. Securities and Exchange Commission made by Exelixis, whether made before or after the date hereof, regardless of any general incorporation language in such filing. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01.  Financial Statements and Exhibits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(d) &#160;&#160;&#160;&#160;Exhibits.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.553%"><tr><td style="width:1.0%"></td><td style="width:8.914%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.995%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.429%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.995%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.967%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exel20230331exhibit991.htm">Press Release issued May 9, 2023</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i3ae763590f6f4a6f957c5f00562ea37a_10"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES </span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </span></div><div style="margin-top:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:71.428%"><tr><td style="width:1.0%"></td><td style="width:26.608%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.526%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">E</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">XELIXIS, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NC.</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 9, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Jeffrey J. Hessekiel</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Jeffrey J. Hessekiel</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, General Counsel <br/>and Secretary</span></td></tr></table></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exel20230331exhibit991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ie27b7f910918485481aa7ecd6d49c443_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-top:9pt"><img alt="exelixis_logoxrgbx2023.jpg" src="exelixis_logoxrgbx2023.jpg" style="height:47px;margin-bottom:5pt;vertical-align:text-bottom;width:177px"></div><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Contacts&#58;</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Chris Senner</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Chief Financial Officer</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Exelixis, Inc.</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">650-837-7240</font></div><div style="text-align:right"><font style="color:#006ba6;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">csenner&#64;exelixis.com</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Susan Hubbard</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">EVP, Public Affairs &#38; Investor Relations</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Exelixis, Inc.</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">650-837-8194</font></div><div style="text-align:right"><font style="color:#006ba6;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">shubbard&#64;exelixis.com</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Exelixis Announces First Quarter 2023 Financial Results and Provides Corporate Update</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">- Total Revenues of $408.8 million, Cabozantinib Franchise U.S. Net Product Revenues of $363.4 million -</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">- GAAP Diluted EPS of $0.12, Non-GAAP Diluted EPS of $0.16 -</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">- Conference Call and Webcast Today at 5&#58;00 PM Eastern Time -</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ALAMEDA, Calif. &#8211; May&#160;9, 2023</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">-</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> Exelixis, Inc. (Nasdaq&#58; EXEL) today reported financial results for the first quarter of 2023 and provided an update on progress toward achieving key corporate objectives, as well as commercial, clinical and pipeline development milestones.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;The Exelixis team continued to execute on our key priorities and made significant progress in advancing our commercial business and our growing pipeline,&#8221; said Michael M. Morrissey, Ph.D., President and Chief Executive Officer, Exelixis. &#8220;CABOMETYX&#174; maintained its status as the leading tyrosine kinase inhibitor in renal cell carcinoma in the first quarter, driven by its use in combination with nivolumab in the first-line setting. We&#8217;ve made important progress across our pipeline programs, including advancing the STELLAR-303 and STELLAR-304 phase 3 trials for zanzalintinib, as well as single-agent and combination dose-escalation cohorts of the phase 1 trial of XB002. We are on track to initiate additional pivotal studies for zanzalintinib in 2023 and are focused on accelerating XB002 into full development by year-end.&#8221;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Dr. Morrissey continued&#58; &#8220;Our collaborations with Cybrexa and Sairopa also made steady progress. Sairopa received clearance of its Investigational New Drug application for ADU-1805 from the U.S. Food and Drug Administration in February and subsequently initiated the phase 1 study in March. Cybrexa is planning to present updated phase 1 data for CBX-12 at the ASCO Annual Meeting in June. In March, we announced a share repurchase program for up to $550 million of our common stock before the end of 2023, which reflects continued confidence in our long-term prospects and the strength of our balance sheet and reinforces our commitment to deliver value to shareholders. I&#8217;d like to thank the entire Exelixis team for their collective hard work and dedication to improving the standard-of-care for patients while driving sustainable, long-term value for shareholders as we advance our mission to help cancer patients recover stronger and live longer.&#8221;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">First Quarter 2023 Financial Results</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Total revenues </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">for the quarter ended March&#160;31, 2023 were $408.8 million, as compared to $356.0 million for the comparable period in 2022. </font></div><div style="text-align:justify"><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;- more - </font></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.228%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Exelixis First Quarter 2023 Financial Results</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Page 2 of 8</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">May 9, 2023</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Total revenues for the quarter ended March&#160;31, 2023 included net product revenues of $363.4 million, as compared to $310.3 million for the comparable period in 2022. The increase in net product revenues was primarily due to an increase in sales volume and an increase in average net selling price. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Collaboration revenues, composed of license revenues and collaboration services revenues, were $45.4 million for the quarter ended March&#160;31, 2023, as compared to $45.7 million for the comparable period in 2022. The decrease in collaboration revenues was primarily related to a decrease in development cost reimbursements earned, which was offset by higher royalty revenues for the sales of cabozantinib outside of the U.S. generated by Exelixis&#8217; collaboration partners, Ipsen Pharma SAS and Takeda Pharmaceutical Company Limited.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Research and development expenses</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> for the quarter ended March&#160;31, 2023 were $234.2 million, as compared to $156.7 million for the comparable period in 2022. The increase in research and development expenses was primarily related to increases in license and other collaboration costs, personnel expenses and manufacturing costs to support our development candidates, which were partially offset by lower stock-based compensation expense. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Selling, general and administrative expenses</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> for the quarter ended March&#160;31, 2023 were $131.4 million, as compared to $102.9 million for the comparable period in 2022. The increase in selling, general and administrative expenses was primarily related to an increase in personnel expenses.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Provision for income taxes </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">for the quarter ended March&#160;31, 2023 was $8.3 million, as compared to $16.7 million for the comparable period in 2022, primarily due to a decrease in pre-tax income.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">GAAP net income </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">for the quarter ended March&#160;31, 2023 was $40.0 million, or $0.12 per share, basic and diluted, as compared to GAAP net income of $68.6 million, or $0.21 per share, basic and diluted, for the comparable period in 2022. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Non-GAAP net income </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">for the quarter ended March&#160;31, 2023 was $52.8 million, or $0.16 per share, basic and diluted, as compared to non-GAAP net income of $83.9 million, or $0.26 per share, basic and diluted, for the comparable period in 2022. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Non-GAAP Financial Measures</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">To supplement Exelixis&#8217; financial results presented in accordance with U.S. Generally Accepted Accounting Principles (GAAP), Exelixis presents non-GAAP net income (and the related per share measures), which excludes from GAAP net income (and the related per share measures) stock-based compensation expense, adjusted for the related income tax effect for all periods presented. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Exelixis believes that the presentation of these non-GAAP financial measures provides useful supplementary information to, and facilitates additional analysis by, investors. In particular, Exelixis believes that these non-GAAP financial measures, when considered together with its financial information prepared in accordance with GAAP, can enhance investors&#8217; and analysts&#8217; ability to meaningfully compare Exelixis&#8217; results from period to period, and to identify operating trends in Exelixis&#8217; business. Exelixis has excluded stock-based compensation expense, adjusted for the related income tax effect, because it is a non-cash item that may vary significantly from period to period as a result of changes not directly or immediately related to the operational performance for the periods presented. Exelixis also regularly uses these non-GAAP financial measures internally to understand, manage and evaluate its business and to make operating decisions. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">These non-GAAP financial measures are in addition to, not a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. Exelixis encourages investors to carefully consider its results </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;- more - </font></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.228%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Exelixis First Quarter 2023 Financial Results</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Page 3 of 8</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">May 9, 2023</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">under GAAP, as well as its supplemental non-GAAP financial information and the reconciliation between these presentations, to more fully understand Exelixis&#8217; business. Reconciliations between GAAP and non-GAAP results are presented in the tables of this release.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">2023 Financial Guidance</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Exelixis is maintaining the previously provided financial guidance for fiscal year 2023&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.851%"><tr><td style="width:1.0%"></td><td style="width:56.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.396%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.480%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </font></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.775 billion - $1.875 billion</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product revenues </font></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.575 billion - $1.675 billion</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0% - 5.0% of net product revenues</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,000 million - $1,050 million</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$475 million - $525 million</font></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20% - 22%</font></div></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">____________________</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes $45 million of non-cash stock-based compensation expense.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes $55 million of non-cash stock-based compensation expense.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Cabozantinib Highlights</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Cabozantinib Franchise Net Product Revenues and Royalties.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> Net product revenues generated by the cabozantinib franchise in the U.S. were $363.4 million during the first quarter of 2023, with net product revenues of $361.8 million from CABOMETYX&#174; (cabozantinib) and $1.6 million from COMETRIQ&#174; (cabozantinib).</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Based upon cabozantinib-related net product revenues generated by Exelixis&#8217; collaboration partners during the quarter ended March&#160;31, 2023, Exelixis earned</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> $32.7 million in royalty revenues.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Cabozantinib Data at the 2023 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium (ASCO GU 2023). </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In February, cabozantinib was the subject of multiple data presentations at ASCO GU 2023, held from February 16-18, 2023. Notable presentations included&#58; 44-month median follow-up data and biomarker analyses from CheckMate -9ER, the phase 3 pivotal trial of cabozantinib in combination with nivolumab&#59; outcomes by International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) risk score in COSMIC-313, the phase 3 pivotal trial of cabozantinib, nivolumab and ipilimumab&#59; and extended follow-up results from a non-clear cell renal cell carcinoma (RCC) cohort of COSMIC-021, the ongoing phase 1b trial of cabozantinib in combination with atezolizumab.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Cabozantinib Data Presentations at the 2023 ASCO Annual Meeting.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> In June 2023, cabozantinib will be the subject of 22 presentations at this year&#8217;s ASCO Annual Meeting, which is being held from June 2-6 in Chicago. Notable presentations will include results from the CONTACT-03 phase 3 trial evaluating the combination of cabozantinib and atezolizumab vs. cabozantinib alone in metastatic RCC patients who have progressed following treatment with an immune checkpoint inhibitor therapy, and three-year quality-of-life follow-up data from CheckMate -9ER. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Corporate Updates</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Announcement of Key Priorities and Anticipated Milestones for 2023.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> In January 2023, Exelixis announced its key priorities and anticipated milestones for 2023, including&#58; pivotal data readouts from the ongoing phase 3 studies evaluating the combination of cabozantinib with atezolizumab in patients with forms of metastatic castration-resistant prostate cancer (CONTACT-02) and RCC (CONTACT-03), the latter of which has subsequently occurred, and the next overall survival(OS) analysis from the phase 3 COSMIC-313 pivotal study for cabozantinib&#59; </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;- more - </font></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.228%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Exelixis First Quarter 2023 Financial Results</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Page 4 of 8</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">May 9, 2023</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">expansion of the pivotal development program for zanzalintinib with multiple new phase 3 pivotal trial initiations&#59; acceleration of the XB002 clinical program into full development by year-end&#59; advancement of the XL102 QUARTZ-101 phase 1 study into the tumor-specific cohort-expansion stage and in planned combination cohorts&#59; in collaboration with partner Cybrexa, progression of the phase 1 clinical study for CBX-12, including dose-expansion cohorts&#59; expected filing of an Investigational New Drug application (IND) for ADU-1805 with the U.S. Food and Drug Administration (FDA) in the first quarter of 2023 by partner Sairopa B.V. (Sairopa), which has subsequently occurred&#59; advancement of development candidates (DCs) XB010, XB014 and XB628 toward IND filings&#59; and progress up to five new DCs into preclinical development across biotherapeutics and small molecules. Exelixis presented the details of its key priorities and anticipated milestones at the 41</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> Annual J.P. Morgan Healthcare Conference.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Cabozantinib Abbreviated New Drug Application (ANDA) Litigation Against MSN Pharmaceuticals, Inc. (MSN). </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In January 2023, the U.S. District Court for the District of Delaware (the Delaware District Court) ruled in Exelixis&#8217; favor in the ANDA lawsuit against MSN (MSN I), rejecting MSN&#8217;s challenge to the cabozantinib compound patent (U.S. Patent No. 7,759,473). Additionally, the District Court ruled that MSN&#8217;s proposed ANDA product does not infringe Exelixis&#8217; N-2 polymorph patent (U.S. Patent No. 8,877,776), expiring in October 2030. The decision in MSN I does not address the validity of the &#8216;776 patent, which was not contested by MSN, and the Delaware District Court entered judgment that any final FDA approval of MSN&#8217;s ANDA shall not be a date earlier than August 14, 2026, the expiration date of the &#8216;473 patent. In addition, this ruling in MSN I does not impact Exelixis&#8217; separate and ongoing suit against MSN (MSN II) concerning four different Orange Book-listed patents related to cabozantinib, which expire between January 15, 2030, and February 10, 2032. A bench trial in MSN II is scheduled to begin in October 2023 in the U.S. District Court for the District of Delaware.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Announcement of $550 Million Share Repurchase Program.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> In March, Exelixis announced that the company&#8217;s Board of Directors authorized the repurchase of up to $550 million of the company&#8217;s common stock before the end of 2023. Share repurchases under the program may be made from time to time through a variety of methods, which may include open market purchases, in block trades, accelerated share repurchase transactions, exchange transactions, or any combination of such methods. The timing and amount of any share repurchases under the share repurchase program will be based on a variety of factors, including ongoing assessments of the capital needs of the business, alternative investment opportunities, the market price of Exelixis&#8217; common stock and general market conditions.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Pipeline Highlights</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Exelixis and Sairopa Announce FDA Clearance of IND for ADU-1805 in Patients with Advanced Solid Tumors.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> In February, Exelixis and Sairopa announced FDA clearance of Sairopa&#8217;s IND to evaluate the safety and pharmacokinetics in a Phase 1 clinical trial of ADU-1805 in adults with advanced solid tumors, which has since been initiated. As a monoclonal antibody active against all human alleles of SIRP&#945;, ADU-1805 has the potential to address a broader patient population than other SIRP&#945;-directed therapies. By blocking SIRP&#945;, a significant immune-suppressive component of the tumor microenvironment, ADU-1805 has the potential to improve the immune system&#8217;s ability to attack tumors. Under the terms of the clinical development and option agreement announced in November 2022, Exelixis has the option to obtain an exclusive, worldwide license to develop and commercialize ADU-1805 and other anti-SIRP&#945; antibodies upon review of data from prespecified phase 1 clinical studies to be completed by Sairopa during the option period. This IND clearance triggered a $35.0 million milestone payment to Sairopa, paid in the first quarter of 2023.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;- more - </font></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.228%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Exelixis First Quarter 2023 Financial Results</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Page 5 of 8</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">May 9, 2023</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Basis of Presentation</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Exelixis has adopted a 52- or 53-week fiscal year that generally ends on the Friday closest to December 31</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. For convenience, references in this press release as of and for the fiscal period ended April 1, 2022 is indicated as being as of and for the period ended March 31, 2022.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Conference Call and Webcast</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Exelixis management will discuss the company&#8217;s financial results for the first quarter of 2023 and provide a general business update during a conference call beginning at 5&#58;00 p.m. ET &#47; 2&#58;00 p.m. PT today, Tuesday, May&#160;9, 2023.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">To access the conference call, please register using this</font><font style="color:#3051f2;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#3051f2;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">link</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Upon registration, a dial-in number and unique PIN will be provided to join the call. To access the live webcast link, log onto </font><font style="color:#3051f2;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">www.exelixis.com</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and proceed to the News &#38; Events &#47; Event Calendar page under the Investors &#38; Media heading. Please connect to the company&#8217;s website at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be required to listen to the webcast. A webcast replay of the conference call will also be archived on </font><font style="color:#3051f2;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">www.exelixis.com</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> for one year.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">About Exelixis</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Exelixis is a globally ambitious oncology company innovating next-generation medicines and regimens at the forefront of cancer care. Powered by bi-coastal centers of discovery and development excellence, we are rapidly evolving our product portfolio to target an expanding range of tumor types and indications with our clinically differentiated pipeline of small molecules, antibody-drug conjugates and other biotherapeutics. This comprehensive approach harnesses decades of robust investment in our science and partnerships to advance our investigational programs and extend the impact of our flagship commercial product, CABOMETYX&#174; (cabozantinib). Exelixis is driven by a bold scientific pursuit to create transformational treatments that give more</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">patients hope for the future. For information about the company and its mission to help cancer patients recover stronger and live longer, visit </font><font style="color:#3051f2;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">www.exelixis.com</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, follow &#64;</font><font style="color:#3051f2;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">ExelixisInc</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> on Twitter, like </font><font style="color:#3051f2;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exelixis, Inc.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> on Facebook and follow </font><font style="color:#3051f2;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exelixis</font><font style="color:#3051f2;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">on LinkedIn.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Forward-Looking Statements</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This press release contains forward-looking statements, including, without limitation, statements related to&#58; Exelixis&#8217; research and development expectations for 2023, including initiating additional pivotal studies for zanzalintinib and, by year-end, accelerating XB002 into full development&#59; Exelixis&#8217; expectation that updated phase 1 data for CBX-12 will be presented at the ASCO Annual Meeting in June 2023&#59; Exelixis&#8217; plan to repurchase up to $550 million of its common stock before the end of 2023 as part of its commitment to deliver value to shareholders&#59; Exelixis&#8217; 2023 financial guidance&#59; planned data presentations for cabozantinib at the 2023 ASCO Annual Meeting&#59; Exelixis&#8217; additional key priorities and anticipated milestones for 2023, including issuing pivotal data readouts from CONTACT-02 and the next OS analysis from COSMIC-313, advancing the XL102 QUARTZ-101 phase 1 study into the tumor-specific cohort-expansion stage and in planned combination cohorts, progressing the phase 1 clinical study for CBX-12 with dose-expansion cohorts, advancing of DCs XB010, XB014 and XB628 toward IND filings, and progressing up to five new DCs into preclinical development across biotherapeutics and small molecules&#59; Exelixis&#8217; expectation that the bench trial in MSN II will begin in October 2023 as scheduled&#59; the clinical and therapeutic potential of ADU-1805, including its potential to improve the immune system&#8217;s ability to attack tumors, and Exelixis&#8217; belief that ADU-1805 may address a broader patient population than other SIRP&#945;-directed therapies&#59; and Exelixis&#8217; scientific pursuit to create transformational treatments that give more patients hope for the future. Any statements that refer to expectations, projections or other characterizations of future </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;- more - </font></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.228%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Exelixis First Quarter 2023 Financial Results</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Page 6 of 8</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">May 9, 2023</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">events or circumstances are forward-looking statements and are based upon Exelixis&#8217; current plans, assumptions, beliefs, expectations, estimates and projections. Forward-looking statements involve risks and uncertainties. Actual results and the timing of events could differ materially from those anticipated in the forward-looking statements as a result of these risks and uncertainties, which include, without limitation&#58; the degree of market acceptance of CABOMETYX and other Exelixis products in the indications for which they are approved and in the territories where they are approved, and Exelixis&#8217; and its partners&#8217; ability to obtain or maintain coverage and reimbursement for these products&#59; the effectiveness of CABOMETYX and other Exelixis products in comparison to competing products&#59; the level of costs associated with Exelixis&#8217; commercialization, research and development, in-licensing or acquisition of product candidates, and other activities&#59; Exelixis&#8217; ability to maintain and scale adequate sales, marketing, market access and product distribution capabilities for its products or to enter into and maintain agreements with third parties to do so&#59; the availability of data at the referenced times&#59; the potential failure of cabozantinib, zanzalintinib and other Exelixis product candidates, both alone and in combination with other therapies, to demonstrate safety and&#47;or efficacy in clinical testing&#59; uncertainties inherent in the drug discovery and product development process&#59; Exelixis&#8217; dependence on its relationships with its collaboration partners, including their pursuit of regulatory approvals for partnered compounds in new indications, their adherence to their obligations under relevant collaboration agreements and the level of their investment in the resources necessary to complete clinical trials or successfully commercialize partnered compounds in the territories where they are approved&#59; complexities and the unpredictability of the regulatory review and approval processes in the U.S. and elsewhere&#59; Exelixis&#8217; continuing compliance with applicable legal and regulatory requirements&#59; unexpected concerns that may arise as a result of the occurrence of adverse safety events or additional data analyses of clinical trials evaluating cabozantinib and other Exelixis product candidates&#59; Exelixis&#8217; dependence on third-party vendors for the development, manufacture and supply of its products and product candidates&#59; Exelixis&#8217; ability to protect its intellectual property rights&#59; market competition, including the potential for competitors to obtain approval for generic versions of Exelixis&#8217; marketed products&#59; changes in economic and business conditions, including as a result of the COVID-19 pandemic and other global events&#59; and other factors discussed under the caption &#8220;Risk Factors&#8221; in Exelixis&#8217; Annual Report on Form 10-K filed with the Securities and Exchange Commission (SEC) on February 7, 2023, and in Exelixis&#8217; future filings with the SEC, including, without limitation, Exelixis&#8217; Quarterly Report on Form 10-Q expected to be filed with the SEC on May 9, 2023. All forward-looking statements in this press release are based on information available to Exelixis as of the date of this press release, and Exelixis undertakes no obligation to update or revise any forward-looking statements contained herein, except as required by law.</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Exelixis, the Exelixis logo, CABOMETYX and COMETRIQ are registered trademarks of Exelixis, Inc.</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">-see attached financial tables-</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;- more - </font></td></tr></table></div></div></div><div id="ie27b7f910918485481aa7ecd6d49c443_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.228%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Exelixis First Quarter 2023 Financial Results</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Page 7 of 8</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">May 9, 2023</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">EXELIXIS, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF INCOME </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(in thousands, except per share amounts)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(unaudited)</font></div><div style="margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.851%"><tr><td style="width:1.0%"></td><td style="width:64.622%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.740%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.396%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.742%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended March 31,</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Revenues&#58;</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Net product revenues</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">363,400&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">310,298&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">License revenues</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">38,292&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">32,067&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Collaboration services revenues</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7,096&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">13,615&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total revenues</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">408,788&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">355,980&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Operating expenses&#58;</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Cost of goods sold</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">14,315&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">13,203&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Research and development</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">234,246&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">156,671&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Selling, general and administrative</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">131,397&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">102,863&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total operating expenses</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">379,958&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">272,737&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Income from operations</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">28,830&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">83,243&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Interest income</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">19,502&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,822&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Other income (expense), net</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(54)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">164&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Income before income taxes</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">48,278&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">85,229&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Provision for income taxes</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8,250&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">16,656&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:18pt;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Net income</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">40,028&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">68,573&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Net income per share&#58;</font></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Basic</font></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.12&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.21&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Diluted</font></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.12&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.21&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Basic</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">324,420&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">319,582&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Diluted </font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">326,279&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">323,289&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div id="ie27b7f910918485481aa7ecd6d49c443_7"></div><div style="text-align:center"><font><br></font></div><div style="margin-top:9pt;text-align:center;text-indent:36pt"><font><br></font></div><div style="margin-top:9pt;text-align:center;text-indent:36pt"><font><br></font></div><div style="margin-top:9pt;text-align:center;text-indent:36pt"><font><br></font></div><div style="margin-top:9pt;text-align:center;text-indent:36pt"><font><br></font></div><div style="margin-top:9pt;text-align:center;text-indent:36pt"><font><br></font></div><div style="margin-top:9pt;text-align:center;text-indent:36pt"><font><br></font></div><div style="margin-top:9pt;text-align:center;text-indent:36pt"><font><br></font></div><div style="margin-top:9pt;text-align:center;text-indent:36pt"><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;- more - </font></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.228%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Exelixis First Quarter 2023 Financial Results</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Page 8 of 8</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">May 9, 2023</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">EXELIXIS, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">RECONCILIATION OF GAAP NET INCOME TO NON-GAAP NET INCOME </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(in thousands, except per share amounts)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(unaudited)</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.851%"><tr><td style="width:1.0%"></td><td style="width:64.622%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.740%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.396%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.742%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended March 31,</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">GAAP net income</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">40,028&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">68,573&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Adjustments&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Stock-based compensation - research and development expenses </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,252&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8,899&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Stock-based compensation - selling, general and administrative expenses </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</font></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">13,409&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10,860&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Income tax effect of the above adjustments</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(3,861)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(4,439)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Non-GAAP net income</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">52,828&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">83,893&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">GAAP net income per share&#58;</font></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Basic</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.12&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.21&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Diluted </font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.12&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.21&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Non-GAAP net income per share&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Basic</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.16&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.26&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Diluted </font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.16&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">0.26&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Basic</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">324,420&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">319,582&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Diluted </font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">326,279&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">323,289&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">____________________</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Non-cash stock-based compensation expense used for GAAP reporting in accordance with Accounting Standards Codification Topic 718, </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Compensation&#8212;Stock Compensation</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</font></div><div style="padding-left:18pt;text-indent:-18pt"><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>exel-20230509.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:897e643e-4be9-4b6f-aa4e-b65e51dbad21,g:fe04d92b-85f9-48b7-ab16-4989ee371866-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:exel="http://www.exelixis.com/20230509" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.exelixis.com/20230509">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="exel-20230509_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="exel-20230509_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.exelixis.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>exel-20230509_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:897e643e-4be9-4b6f-aa4e-b65e51dbad21,g:fe04d92b-85f9-48b7-ab16-4989ee371866-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_EntityTaxIdentificationNumber_77277a31-7a35-40b5-8fce-73e87dd7d1b4_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_9a54eeac-78d7-4ac5-89d0-0b18afabda90_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_0baec941-4a14-4c9d-96dc-75eed6372838_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_74b9d46e-6df4-4b5a-a86f-b0bc080643fd_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_c7f9a4bb-0e30-4fae-a45e-86cf59bc8821_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_8a494785-15ab-48ad-aeb4-413b9e628c4e_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_3e9a331b-82a2-492e-bcf6-4db704653ea6_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_11aed2b0-51ff-4e5b-8386-665448b13713_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_a5891577-c9fc-495a-9bdd-cda5dd247288_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_435edd4e-7171-4447-9fe5-e683f902b8a4_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_ac8b3b10-800f-46ff-8811-05744208af79_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_48c3689b-dad9-4210-8aaa-04bc450f30e1_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_f4b1b71c-b234-44eb-ada4-723928d36f9f_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_cf1688fe-e496-48e6-9ff5-97c6d3cc4bdd_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_32fe3628-fa2b-4505-871b-267fa37ffe8b_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_b3f1352a-4dc9-4255-b61f-d781a093d536_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_56379299-507e-4b0e-b63d-1c667d3c622e_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_42f492fa-5566-475f-a497-2a5bc183c5ee_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_c794eff6-ce6b-491e-9452-a92b795583b1_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_a4df6f64-aafd-4f5b-a8d8-529b31ea5b3e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_ff00458e-c661-4477-a0b3-bcd0602f031d_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_a6e1603d-e19a-47e4-b158-962a9065d273_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_884d5ff2-ca94-47bb-8cda-dc06596f1305_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>exel-20230509_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:897e643e-4be9-4b6f-aa4e-b65e51dbad21,g:fe04d92b-85f9-48b7-ab16-4989ee371866-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.exelixis.com/role/CoverPage" xlink:type="simple" xlink:href="exel-20230509.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.exelixis.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_b514a1f0-6cc5-4fba-8652-3cbd04797374" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_bf7b1942-b3ad-4a81-877d-439ef72e1dbc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b514a1f0-6cc5-4fba-8652-3cbd04797374" xlink:to="loc_dei_AmendmentFlag_bf7b1942-b3ad-4a81-877d-439ef72e1dbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_d1d90916-2e40-4514-aa9c-857601ee0cad" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b514a1f0-6cc5-4fba-8652-3cbd04797374" xlink:to="loc_dei_DocumentPeriodEndDate_d1d90916-2e40-4514-aa9c-857601ee0cad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_8d7ae966-d639-441f-9374-fe3b2654d6b5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b514a1f0-6cc5-4fba-8652-3cbd04797374" xlink:to="loc_dei_EntityRegistrantName_8d7ae966-d639-441f-9374-fe3b2654d6b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_af6c00a7-afd6-40e8-ad15-93865972df95" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b514a1f0-6cc5-4fba-8652-3cbd04797374" xlink:to="loc_dei_EntityCentralIndexKey_af6c00a7-afd6-40e8-ad15-93865972df95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_ccba8b02-32e3-45c6-a26f-a96e03fc38e2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b514a1f0-6cc5-4fba-8652-3cbd04797374" xlink:to="loc_dei_EntityEmergingGrowthCompany_ccba8b02-32e3-45c6-a26f-a96e03fc38e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_9a01c114-a9e3-44df-b22a-b5c674833151" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b514a1f0-6cc5-4fba-8652-3cbd04797374" xlink:to="loc_dei_Security12bTitle_9a01c114-a9e3-44df-b22a-b5c674833151" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_a42a755b-e839-464c-baa8-5e5a46e7eacc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b514a1f0-6cc5-4fba-8652-3cbd04797374" xlink:to="loc_dei_TradingSymbol_a42a755b-e839-464c-baa8-5e5a46e7eacc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_e416579e-5f94-44d8-bb3a-2e65b51faeb0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b514a1f0-6cc5-4fba-8652-3cbd04797374" xlink:to="loc_dei_SecurityExchangeName_e416579e-5f94-44d8-bb3a-2e65b51faeb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_4670bd08-0f38-41de-bffd-7c6adc5f729a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b514a1f0-6cc5-4fba-8652-3cbd04797374" xlink:to="loc_dei_EntityFileNumber_4670bd08-0f38-41de-bffd-7c6adc5f729a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_0a20580c-fb27-4e5e-9999-4ccbf9f32fbe" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b514a1f0-6cc5-4fba-8652-3cbd04797374" xlink:to="loc_dei_EntityIncorporationStateCountryCode_0a20580c-fb27-4e5e-9999-4ccbf9f32fbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_debfc57d-a24c-4d28-b4a5-d42f13cbcc71" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b514a1f0-6cc5-4fba-8652-3cbd04797374" xlink:to="loc_dei_EntityTaxIdentificationNumber_debfc57d-a24c-4d28-b4a5-d42f13cbcc71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_c9c6457f-7907-4b22-ab37-9c1122a41649" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b514a1f0-6cc5-4fba-8652-3cbd04797374" xlink:to="loc_dei_EntityAddressAddressLine1_c9c6457f-7907-4b22-ab37-9c1122a41649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_02ae447c-6af1-43f9-a404-df0526c63430" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b514a1f0-6cc5-4fba-8652-3cbd04797374" xlink:to="loc_dei_EntityAddressCityOrTown_02ae447c-6af1-43f9-a404-df0526c63430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_1a3d85cf-6ba1-44d2-bc57-c555c8bec116" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b514a1f0-6cc5-4fba-8652-3cbd04797374" xlink:to="loc_dei_EntityAddressStateOrProvince_1a3d85cf-6ba1-44d2-bc57-c555c8bec116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_6a00531c-f14a-4e46-931f-426b639234b1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b514a1f0-6cc5-4fba-8652-3cbd04797374" xlink:to="loc_dei_EntityAddressPostalZipCode_6a00531c-f14a-4e46-931f-426b639234b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_b5181f7c-42d9-48f1-9157-d03b840efff9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b514a1f0-6cc5-4fba-8652-3cbd04797374" xlink:to="loc_dei_CityAreaCode_b5181f7c-42d9-48f1-9157-d03b840efff9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_0b485554-246b-4488-81d8-1ceee68e6cc3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b514a1f0-6cc5-4fba-8652-3cbd04797374" xlink:to="loc_dei_LocalPhoneNumber_0b485554-246b-4488-81d8-1ceee68e6cc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_763bce37-59ed-499b-adfb-10eca2259d84" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b514a1f0-6cc5-4fba-8652-3cbd04797374" xlink:to="loc_dei_WrittenCommunications_763bce37-59ed-499b-adfb-10eca2259d84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_bfe44fad-8ffd-49af-bb6c-6cf71e7cda2b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b514a1f0-6cc5-4fba-8652-3cbd04797374" xlink:to="loc_dei_SolicitingMaterial_bfe44fad-8ffd-49af-bb6c-6cf71e7cda2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_8035da3d-6d58-4153-8e95-696b5daae597" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b514a1f0-6cc5-4fba-8652-3cbd04797374" xlink:to="loc_dei_PreCommencementTenderOffer_8035da3d-6d58-4153-8e95-696b5daae597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_43cfe4cc-326b-4c9d-b275-0314c02b7f22" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b514a1f0-6cc5-4fba-8652-3cbd04797374" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_43cfe4cc-326b-4c9d-b275-0314c02b7f22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_a6f67d5a-8350-4f06-871b-6995be4447ae" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b514a1f0-6cc5-4fba-8652-3cbd04797374" xlink:to="loc_dei_DocumentType_a6f67d5a-8350-4f06-871b-6995be4447ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>exel-20230509_g1.jpg
<TEXT>
begin 644 exel-20230509_g1.jpg
M_]C_X0TO17AI9@  34T *@    @ # $   ,    !#.0   $!  ,    !"?8
M  $"  ,    #    G@$&  ,    !  (   $2  ,    !  $   $5  ,    !
M  ,   $:  4    !    I $;  4    !    K $H  ,    !  (   $Q  (
M   A    M $R  (    4    U8=I  0    !    [    20 "  (  @ "OR
M   G$  *_(   "<0061O8F4@4&AO=&]S:&]P(#(S+C0@*$UA8VEN=&]S:"D
M,C R,CHP-SHR-2 Q.#HQ,#HR-@      !)    <    $,#(S,: !  ,    !
M  $  * "  0    !   $L* #  0    !   !1P         & 0,  P    $
M!@   1H !0    $   %R 1L !0    $   %Z 2@  P    $  @   @$ !
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MDI__V?_M%2I0:&]T;W-H;W @,RXP #A"24T$!       *AP!6@ #&R5'' (
M  (  !P"!0 617AE;&EX:7-?3&]G;U]21T)?,C R,CA"24T$)0      $.Z*
M+VTF;HFD<OR1I?7(F<@X0DE-!#H      0L    0     0      "W!R:6YT
M3W5T<'5T    !0    !0<W138F]O; $     26YT965N=6T     26YT90
M  !#;')M    #W!R:6YT4VEX=&5E;D)I=&)O;VP     "W!R:6YT97).86UE
M5$585    !0 0P!A &X ;P!N "  :0!8 #8 .  P #  ( !S &4 <@!I &4
M<P      #W!R:6YT4')O;V93971U<$]B:F,    , %  <@!O &\ 9@ @ %,
M90!T '4 <       "G!R;V]F4V5T=7     !     $)L=&YE;G5M    #&)U
M:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[      (M    $     $
M     !)P<FEN=$]U='!U=$]P=&EO;G,    7     $-P=&YB;V]L      !#
M;&)R8F]O;       4F=S36)O;VP      $-R;D-B;V]L      !#;G1#8F]O
M;       3&)L<V)O;VP      $YG='9B;V]L      !%;6Q$8F]O;
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M=%5N=$8C4FQT                5&]P(%5N=$8C4FQT
M4V-L(%5N=$8C4')C0%D            08W)O<%=H96Y0<FEN=&EN9V)O;VP
M    #F-R;W!296-T0F]T=&]M;&]N9P         ,8W)O<%)E8W1,969T;&]N
M9P         -8W)O<%)E8W12:6=H=&QO;F<         "V-R;W!296-T5&]P
M;&]N9P      .$))30/M       0 $@    !  $ 2     $  3A"24T$)@
M    #@             _@   .$))300-       $    'CA"24T$&0
M!    !XX0DE- _,       D           $ .$))32<0       *  $
M     3A"24T#]0      2  O9F8  0!L9F8 !@       0 O9F8  0"AF9H
M!@       0 R     0!:    !@       0 U     0 M    !@       3A"
M24T#^       <   _____________________________P/H     /______
M______________________\#Z     #_____________________________
M ^@     _____________________________P/H   X0DE-! @      !
M   !   "0    D      .$))301$       0     @   D    )      #A"
M24T$'@      !      X0DE-!!H      V$    &              %'   $
ML    !8 10!X &4 ; !I '@ :0!S %\ 3 !O &< ;P!? %( 1P!" %\ ,@ P
M #( ,@    $                          0             $L    4<
M                     0                         0     0
M &YU;&P    "    !F)O=6YD<T]B:F,    !        4F-T,0    0
M5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M;&]N9P   4<
M    4F=H=&QO;F<   2P    !G-L:6-E<U9L3',    !3V)J8P    $
M  5S;&EC90   !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG
M          9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N
M97)A=&5D     %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B
M;W5N9'-/8FIC     0       %)C=#$    $     %1O<"!L;VYG
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M=71S971L;VYG          MR:6=H=$]U='-E=&QO;F<      #A"24T$*
M    #     (_\        #A"24T$%       !     $X0DE-! P     "\$
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M!0$! 0$! 0         #  $"! 4&!P@)"@L!  $% 0$! 0$!          $
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M    % !! &0 ;P!B &4 ( !0 &@ ;P!T &\ <P!H &\ <  @ #( ,  R #(
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M1T(                  /;6  $     TRU(4" @
M                                           18W!R=    5     S
M9&5S8P   80   !L=W1P=    ?     48FMP=    @0    4<EA96@   A@
M   49UA96@   BP    48EA96@   D     49&UN9    E0   !P9&UD9
M L0   "(=G5E9    TP   "&=FEE=P   ]0    D;'5M:0   _@    4;65A
M<P  ! P    D=&5C:   !#     ,<E120P  !#P   @,9U120P  !#P   @,
M8E120P  !#P   @,=&5X=     !#;W!Y<FEG:'0@*&,I(#$Y.3@@2&5W;&5T
M="U086-K87)D($-O;7!A;GD  &1E<V,         $G-21T(@245#-C$Y-C8M
M,BXQ               2<U)'0B!)14,V,3DV-BTR+C$
M                                                 %A96B
M  #S40 !     1;,6%E:(                     !865H@        ;Z(
M #CU   #D%A96B        !BF0  MX4  !C:6%E:(        "2@   /A
MML]D97-C         !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M                                9&5S8P         N245#(#8Q.38V
M+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@+2!S4D="
M   N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@+2!S
M4D="                             &1E<V,         +%)E9F5R96YC
M92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$
M "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@245#-C$Y-C8M,BXQ
M                                  !V:65W       3I/X %%\N !#/
M%  #[<P !!,+  -<G@    %865H@      !,"58 4    %<?YVUE87,
M     0                        */     G-I9R      0U)4(&-U<G8
M       $      4 "@ / !0 &0 > ", *  M #( -P [ $  10!* $\ 5 !9
M %X 8P!H &T <@!W 'P @0"& (L D "5 )H GP"D *D K@"R +< O #! ,8
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M^!GXJ/DX^<?Z5_KG^W?\!_R8_2G]NOY+_MS_;?___^X (4%D;V)E &1
M 0, $ ," P8               #_VP"$  (" @(" @(" @(# @(" P0# @(#
M! 4$! 0$! 4&!04%!04%!@8'!P@'!P8)"0H*"0D,# P,# P,# P,# P,# P!
M P,#!00%"08&"0T*"0H-#PX.#@X/#PP,# P,#P\,# P,# P/# P,# P,# P,
M# P,# P,# P,# P,# P,# P,#/_" !$( 4<$L ,!$0 "$0$#$0'_Q $/  $
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M P$! A$#$0   +_
M
M
M                                         #%O'^1Z4Y4Y!QL
M
M#X8^^+]SBOS_ *<F?>X_N],@   !T#X_VZT.BO0-K_H?S3O]L0
M                                                      !COXOW
M:W^D.^\4\>Y)JF.?_9^*?_<72<FN=]>@  #A_P WZJI///I2:7:/4TH>?==
M
M    #C\=ZB_.'I[I?R_J@#7,6F^@/.6:.4<3  &B)K-Z)]!]2^=].U_T/YIU
MS
M       C-P3L&N'I'OGX  28YUP"R#N_H0  0:ZG[BA7U=VS:5W]YSS?ROB
M
M     $,^L.UX)]2]Q@ #,_)^*VH^@O-X $:N#<_K=Z/[\D)S/@]F?>WGP
M
M   1[X9SBLOHGT&0 !*OL+KBPWN?HP 8LX_R.JOS[Z1VF6EM_HWS)D/[7P@
M
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M@  11M6ORU(I6C&J/S/LNPPSG$ROK:>=;YUB0!C:8K0O3M4.()YUOG*)
M%'&F4);5      VAZ@L=^U I0TR@;:H L4K>XW/0  #045:Y0VFH M I>V&F
M@%0&F=;MJ      #T69;9UB0(CVK0IIEJ!E5/I,QV     J?OG5_>GP$MHM?
M7EJ!7]TYW=$GKGLSX 2'YIP>S'O7SZ /QK?\*7WNN( %?737=\3.N^R_I.GM
MKIV9W9_4X \]VN,;Y@"VBFEG-+@ =3*5=<H9374   #X3-K:X&FF5(D59WIW
MX_8Z@<2BTVF@    \UFV.,4      =@/3OCON@<.>>W7'!$P!I+K<])[5N
M*NKTJBOG] )91:^G+7]@#SZ:XQIF      /U/33COW, JWOG5->@&54^DS'8
M    "@77*+$U EM%KZ\M0.'_ #?JJ(\W^H.K?/\ H ?$V6=Y] 2-YMP,   "
M)O779E?'3?=_U'=?J?*MW](>7]YKD!M#RT;8?0"VBFEG-+@#B#S[ZXQ]F
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M"VBFEG-+@8<F/-]KCK +#ZWN0STU             \TVV.-T 6KTO:530
M    #IB/._KEC&8 _0_, &?HGT&Y;<L   >?+7&-<P!8M6]Q>>@      JUO
MG51>@&54^DS'8    "@/7*+4U EM%KZ\M0 !MJ:5+^=/3../B?= )GQV_P!+
M3 [*ZM$+>KNV8,]3]Q$#<WI;CZ.\Q]^^Q\0  ; \M6V&L MHII9S2X'#'E[V
MP_, ^&?XF>M;R[K;.$3K           /--MCC= $Q*VEY%@  !VR)GK6P
M$=)CS]:X\<  #M9Z'LMLL1(   \^6N,:Y@"3\6G#6P   W4+%ZW  JUOG51>
M@&54^DS'8    "@/7*+4U EM%KZ\M0  ,+<6Y;5CY_\ 1WQ '*_H_/;KZ/\
M,.*N/\DK-Z)]!:( 2][)ZPGWW!TH  !L#RU;8:P"VBFEG-+@"B33*'-J@ #0
M=R)/UM+F+37K;(<2         /--MCC=      S/$^CK+8    5Z7I3/?/4
M#47NYZS"K8   #SY:XQKF     !S!ZB<=P *M;YU47H!E5/I,QV     H#UR
MBU-0);1:^O+4   5X=+]Z16Z^[& &;N5<1Q3Q[DO#_F_2!S7ZORV_P#I/RYS
M_P"S\0  &P/+5MAK +:*:6<TN ,,3'GKUQZR    :R:-;6P4TS;$@
M#S3;8XW0     ,\Q/HHRV    'YGF^UQQ', "4T6O[RU    'GRUQC7,
M #MYZ<L=P *M;YU47H!E5/I,QV     H#URBU-0);1:^O+4   8T^%R"I#SE
MZ;U3 'U/Q  D[SSKZQONWH8   ; \M6V&L MHII9S2X & 9BD73+"TP    .
M1+I,]9V5L       !YIML<;H     TEO]-+)*7    %5M\ZL+T  TET&>E@=
M;@   >?+7&-<P    !\+-Z7MKIH !5K?.JB] ,JI])F.P    % >N46IJ!+:
M+7UY:@  "O/ICO**?7O9 !,IN?\ 7,9."=@[3/0#][5MD]$^:,F_>X\  !L#
MRU;8:P"VBFEG-+@ #:D%[4K_ +UBO-?P   !NCT)9;2%B0      !YIML<;H
M E_6TMHL  !G^)E;6P    A]:M$6F6@  ')GH*RVD)$@  #SY:XQKF )-Q,V
MJW   S'$S(K;Z  5:WSJHO0#*J?29CL    !0'KE%J:@2VBU]>6H  &-/A<@
MJ5\Z>F=$2!('F/"K-.]_/<)NJ^W82=5]N? #,7)>+VI^@_-VN8  &P/+5MAK
M +:*:6<TN   !U\BW:L7IK%BU8X3'X@ $VJVO'SU       'FFVQQN@"U>E[
M2J:        8IF//!KCU, Y(V1^0!E)/H?RU[A$@  >?+7&-<P!8M6]Q>>@
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M->0?L_# P=Q/F%7'07HL@#G/U_DMV]'^8.S?O^> !L#RU;8:P"VBFEG-+@
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M*GO/'I;9Y: ;O3.VOT7YER%]KX8V!Y:ML-8-9Z$<MI&Q( ZV53Z9UUVIQP
M !^Y976]L^>FX        *6=,^F3     'TR?$VB4OD6)$/[5KFO0 97B;?\
M]-8   /Q*YKTBG-=C(:2U//21$2*CM,\+S      [Y"SRFF88D 07M2!UZ@
M  #L$+%:WE)6P%36F>"YC<0E)%K**7_4 K^Z<[MB1USV;N;UM'[^\YYHY1Q,
M     8FX[R:(?6W:'7_Q_M S5RGB4R^SNJ1M"B_7+4<O"?5;S(K8  #I$Q!>
MU8BS6/MHQZC9&HY\S=$RVK:P2M\PQ(
M                    Q[\;[E2'G+TYMZ7L)[EZ/EAV)UH
M    !MSB#]CF#Z
M      5H=%^@8[\*YS++L7K2P7N3I
M                                          86XORVJ_S]Z.S5RCB=
MH_?WG/<7H
M                    !IB:I?/7I/JWS_I6P>B/-/9?W?/
M                                                           $
M9^"=@UW]+]Z6I^@O-V5>0\;
M                                   &USTJ(\W^H9U=M=-27YUU^
M
M         !#?K+M7KWXOW3I[:Z<
M                                        &!.(<TSSR[AFJ8
M
M
M                                                       __]H
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MC3+QB;C/,:P5*@C&,8<90ED55\!0*%0D++*BX*3& ("&F?3 PMW8#!G,'Z>
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M5U0ZG%827+'Q%YH3\@^].,B"L'2HMR^(^)H'R%#/LW4&ZAG,._@0XUAQ -V
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M<(JG4>['Z"5F^@E9OH)6:4T%628K'L#=@;L#";?0 =F [ 8&WR]@83L(B/\
MN=?5RI<&=X=X81V:2)7&#)_HV_\ NR>%OW^,:1Y8]Z/[$IN6_A<$ ;-*TN&6
M'[MV5V7V(B.S32M"J1J.DOE2)34YRGP_L2GM;]RA(:&>1#R6T!VCPWL2>O2N
MB+:J=4C),ECX<Z]B=1%K_&ZD66.X^Q0),@WD6   ?\:__]H " $#  $% /\
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M/WPXCO@N*Q$J"?OSOWF@3,8=]4!V8H[X?_1^!W "A^AN=(>=4I=LHANPAME
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M[F:WJ:?+\:$_?'3O7_)W&QC\F\T9"0T?"55IY%4SG+):S4[XJE87*5H-!E
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MR401)^UI-@%YHV\,(+8HZJ"P:[SF3H+N\@19CQ 7DX "LT7=Y-U;->[7L?P
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M0?=IE7*%1ZK#FMQ7Y$T>1-$'0D$9C[5>0VHB2E;M^"+VF]0KUJDL!54  "P
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M7L@Y9H\O4"*.ODA3&HJ7&V2IJ&QDF<\[.Q/XN0]NS?E>U9GHI%*&FN=)#5*
M=1W>M5MTZ]HUZ3UG#RX5W#.[D%HJ6%FN%J9@#@&I:A]] 3_I2KAT:3',F4ZB
M\6%#[SG"P1RU]O=>8R;B=; >U*BCH8[=.K:JB279U+. ^/M3K_NTAI,CY.K:
MBB=PM1F:X1R45IIP=K254J@/@->[$'8\PTGIJ6<7[.E]6-\VYNDCW&G9,2E/
M3H2>JIXB3NKCB3BS$DZO0EIZB))X)T:.:"10R.C#!E93B""#@0=)N('_ &U9
M_J>$>9I"Q>Q;\JVW!SO/'!)#C)#&Q_RG26+UJJ-6B6V.[Y/KH$'5B^.+<7(V
M;YQAC)/_ *7IC2CSC_W3<5*K/DU&V]391MLTHI@C'%H6J"L(BC)U,M-%&6&U
M]*"RV2WT]IM%K@2FMMMI(UB@@AC&ZD<:* %  U =CXN??2^^/S<CC7]8V/Q>
MI_ :[CQD.WXP28/Q/LM,FL:MT7>-%VX:EJ,.;"3F<Z @X@[".0V5LUUSKPMS
MA4C^8.Y+)9[C)@B5ZCFBDU+.!LU2>I;&.:&198I5#Q2H0RLK#$,I&H@C8=+E
M?;W70VRSVBFEK+G<:A@D4$$*EY)'8[ J@G1[M"T]'D3+S2TV1+)+BI$3'"2O
MG38)JD '#U"8)MWL?1:21@B("SL=@ VZ0\7L]6\Q9YS)2%<LVBH3"2SVR<=\
MZGO:BI7 OSHF";2XY?%;X[0?9E)R.)GW8H_'#V?@I]8WSQ>FY'!S[YV?QE.R
M<1OU%F^SH>1DSZJOGB9Y5URO7D1/4J);96X8M35D6)AF7VK:CTJ2.?2X66[4
MYI+I::AZ6X4Q]1+&<#@><'45/."#R(*FEG>EJZ61)J2JC.Z\4L9#(ZGF*L 1
MI1W:1DCOMO(HLRT:X#JZI%&+JO,DHP=?3PYN377B[UD=OMEMA>HKJR8X)'&@
MQ)/_ - -9V#1KE)UM+EZVEXLLVA]751'4T\J[.MEP!;UHP7F./H$[K.=05%&
M+,3J  YR3J TI*:NA"9COA6X9B;U2RNOO<&/1"F"^GO'GY5R^*S>X.A]N_NC
MR.+_ -?V[Q$<CBE>8M4MORK=I8"/]04D@39[(C2"(;(HU0?B '(:\01**_,F
M9;K/<JC ;SFEE%'$I.W!4A& [9[ :N7+EKEJB=XU+T<#28].\4QT554*J@!5
M P  V #\#XN??2^^/S<CC7]8V/Q>I_ 9J:IACJ*:IC:*HIY5#I(C@JRLK8@@
M@X$'3^<9?IG?A=F^I=LN2C%A:ZML7>V2MKP7#%H"=J8IK*:_1*L RL"&4ZP0
M=H(TM_ ?/EQ)K*6-DX9WJI?7/!&"QM4CMMDB4$PD]\@W-J &JX.9'N/69+R[
M5!<ZW6G;WNZW&G;'X&C#OH*9QW?,\HPUA-?(I.+>=J$/D++-9CEBUSJ"EXN=
M.W^,Z-WU/2N.?4\@PUA&!Y?%;X[0?9E)R.)GW8H_'#V?@I]8WSQ>FY'!S[YV
M?QE.R<1OU%F^SH>1DSZJOGB9Y<7$ZSP8S4,:4N;84&MZ8=S#58=,1.ZWL2#Z
MGDTUVJ'<Y>NBK19FIUUX0%L4J /70,=[I*[PY](JBGE2>"=%D@F0AE=&&*LI
M&H@@X@^B6)  UDG8!HV4\N5!.3;+.?A-4A[FYU<1PW]6V&(CN/7-W6P+R#F*
MXP"3+^3'2=E<8I/<&&]3QZ]HC'OC=O=Z>7<OBLWN#H?;O[H\CB_]?V[Q$<CB
M_3P+OROE&[E5&LG<I9&(&':&B$:P5!!_%R*_A/G^X):,N9AN)K\IYCJ65*6C
MKJ@*D]+52-@(TF959'8[H?>#8;P.B21L'1P&1U.((.L$$;0?POBY]]+[X_-R
M.-?UC8_%ZG\"OF1LWT(K[%?J<PU* [LD3@[T4\+[4DB<!T8;"-+GD/,P-0],
M/A-AO83<BN=N=BL55&-@.K=D4'N7!&S#'T8:BGFDIZBG=9:>IA=HY(Y%.*NC
MJ0RL#K!!Q&G]Y],ZR>0EA0ST.3;'U55GN_Q=R8:9R=RDA?# 3U.!"^M7>?F&
M-JR[EZW0VBQV2EBHK5;*==V*""%0J(H[0'/K//V#BM\=H/LRDY'$S[L4?CA[
M/P4^L;YXO3<C@Y]\[/XRG9.(WZBS?9T/(R9]57SQ,\NJH:V%*FCK87@JZ:08
MI)%(I5T8<X()!TK\NOOR6J8&LRW6-KZVB=L%4GG>(]PWXCS\C6,1SC1^'%YJ
M,;G8(C-ER:1NZGMX.!AQ.LM3DX#V!'K3Z-7PURG6%:R>/<S?=8&P,$3C^"C8
M;'D4^^$=ZO<[6U!5 50,%4:@ .8>C1VVW4[5=PN,\=+04B#%I9IF"(@PZ2=+
M1EBE*RSTZ&:[5@&'PBLF[J>7TBVI>A0!R[E\5F]P=#[=_='D<7_K^W>(CD7V
MP3G=@OENJK?,QUX)4Q-$Q_(VE99JU&CK;+4SVZLC;OA+22-!(#_S(>0RLH96
M&#*1B"#M!&E-;LKYH_FF6:8C<RA?4:NH40$DI Q99H <=D<@7V.D%-Q(R#=<
MLU.Z!/=;+(ETHR^.WJFZFH0=H*^B1Y;XG622L8 _RRNG_E]4"?4]16"%R1V@
M=$EB=98I &CD0AE8'801J(_".+GWTOOC\W(S[!?\LW7,39OJK?/2-;&IU$(H
MXI8V$G7R1ZV,@(PQT\VN:?VE!\XT\VN:?VE!\XT\VN:?VE!\XT\VN:?VE!\X
MT\VN:?VE!\XT\VN:?VE!\XT\VN:?VE!\XT\VN:?VE!\XTRED6AR!F.WUN;[G
M%;*2NJ9*(PPO*&(>0),S8#=YACV*2T%HK=G*Q=969(S Z_P]45P:"8C68)P
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M@RL#@58'80=1'(M69[))U=SL\XF@4DA94V20OAZB5"5/IX\VEHS19I-^BNT
ME$9/=Q2#5)$XYFC8%3VQRKE\5F]P=#[=_='D<7_K^W>(C\ R)Q/ME.M-79K%
M18\S;BA1/+1QB:CG<\[B/?C)YU"]'(LW5X=9_,J+JL=F_P#"(]W'\>@QV\^'
MX!Q<^^E]\?FY'&OZQL?B]3^ U/"3)-Q#Y"RS589JN=.V*7BYT[?X"NNIJ>E<
M:\-3RC'6$&/(IN,6>+:),D9>J2<F6NH7%+K<8&P-6RGOH*9QW&.IY1CK5->D
ML$\23P3HT<T,BAD=&&#*RG$$$' @Z#,>6*)QPMSA5-_)]P%DM%>^+O;G/-&V
M!:G)YL8]JC'T2" 0=1!V'2@X#9\N(."E.&%[J7ULB@LUHD=MK( 33DZRN,>U
M4!Y7%;X[0?9E)R.)GW8H_'#V?@I]8WSQ>FY'!S[YV?QE.R<1OU%F^SH>1DSZ
MJOGB9Y3RRNL442EY)'(5551B22=0 &ERO4,C-9*#&WY;B.SX+$QQEPYC,^+^
MENCF]&&GIX9*FIJ9%AIJ:)2\DLDA"HB*-99B0 -&N5WCCFSI?8E-VG7!A2Q=
M\E'$W0NUR.^;M!>4,[6BGW,OYKG(N,:#N:6Y$8L>@+4 %A[,-TCDG)EWJ-S+
MV;)Q\ D<X)2W,@*O:"U  4^R"])Y5R^*S>X.A]N_NCR.+_U_;O$1R:V_9EO%
M'8;+;HS+776OF2GIXE'.\DA"CH&O7I-29<I,P9Z:%MWX?;J1:>C?MI-6/"SC
MMJA';T2',66,TY7CD*J:UJ:"NA3$ZRXI96D ':0Z1YBR'F>@S39Y#NFKH90_
M5OSQS1G!XG'.KJ&[78,A<,[?.)JO*L51?,Q!3B(I:Y%AHX6',QC5W]JR]/(X
M<9=C&\]YS3:*<+['X7&[G\2J2?P'BY]]+[X_-R.+*9]SK9\H/>*ZT26I+K5Q
MTQJ%A@J%D:(2$;P4L <-F.GGGRCY4I_TM///E'RI3_I:>>?*/E2G_2T\\^4?
M*E/^EIYY\H^5*?\ 2T\\^4?*E/\ I:>>?*/E2G_2T\\^4?*E/^EIYY\H^5*?
M]+1G?C3E!40%G8W6GP &LD]UI35M',E325D23TM1&0R21R*&1U(V@@@@\F;A
M%D6X=5GK,M)O9ENT#=W9[9.",%([VHJ5Q"<Z)C)M*'18XU"H@ 51S <A;1()
MZ/(N7FBJ<^7R+%2L+'&.A@DPP$]0 1CZA,7];C;;%9*"&UV>T4T=);+=3J$B
M@@A4)'&BC8% P]&^9)S=;UN5@S!3FGKJ<G===89)8GVI)&P#HPV, =+GD7,)
M>JBC!J\M7XIN1W.W,Q6.H7F#J>XE4=Z_:*D^C#44\\E+54TJ3TE7"Q26&6)@
M\<D;C6K(P!!&PZ26',LL</$[)T$:9@B7!5N-+J2*Y0IS!SW,JC4DGL67E<5O
MCM!]F4G(X@7+/6:[7E*@N&7Z6FH*NZU,=-'-,E67:.-I" S!3B0.;3SSY1\J
M4_Z6GGGRCY4I_P!+3SSY1\J4_P"EIYY\H^5*?]+3SSY1\J4_Z6GGGRCY4I_T
MM///E'RI3_I:>>?*/E2G_2T\\^4?*E/^EIYY\H^5*?\ 2TMM_L%RI[Q9+Q3I
M5VNZTD@E@J()1O))&ZXAE8'$$<C@I]8WSQ>FY'"V]7BMAMMIM&:K7672XU#!
M(:>GAJ%:261SJ55 Q).A'_\ L^4-71=:<_\ YZ>>?*/E2G_2T\\^4?*E/^EI
MYY\H^5*?]+3SSY1\J4_Z6GGGRCY4I_TM///E'RI3_I:>>?*/E2G_ $M)[SD;
M,]MS7:J:I:DJ+A:ZA*B%)T56:)G0D!@&!([?H\1OU%F^SH>1DSZJOGB9Y463
M+74&.]YP1UJW0D/!;5.[,V(V&4^]CM;W1H !@!J '-Z!9B%51BS'4 !SG2EX
MDYJHB+E51[^4K7.N!IH)!_%NIV22J>XQ[U3CM;5RKOE>\Q[]!=H&B=QW\3[8
MY4/,T; ,.V-+MEB]Q[ERL\YAE< A9D/=13ICZF1"&'Y.;D=\5((*NIP92#B"
M"-A!U@Z)'<9PV:<N;E'?U/?3:O>:H#HE4:^A@PY-R^*S>X.A]N_NCR.+_P!?
MV[Q$<B]9KS)<(K78<OT<M==:^8@+'#"I9CVR=B@:R< -9TENEXDFMV3K=.QR
M;DK>]YI(AJ2HJ%&J2I<:V8X[F.XF &OT(LSY$S'6Y7OL> >LHGP6=%./5U,+
M!HYTU=[(I'1AI3VSC+DYW*@(V;LL+OAL!AO3VZ5]X$G63%(W:0:1-DSB'9KI
M52;H_E,E0*6N5F&.ZU)4=7,"/:\B:MKZJ&BHZ92]15U#K'%&HVL[L0 .V3I7
M9>X3U%-Q!SLP:%;K"=^R6Y]8+RU"D"I==HCA)!]4ZZ77,-_N,UWOM\JI*V[W
M2H.,L\\IQ9VPU <P U*  -0Y%LO,L EM?#NVU-[JW8:A53J:.C4'IQD=Q[3\
M!XN??2^^/S=FK?U$GN3IDWZCMWBT?(FO 6*X9ROO6461[ YU3U>[W4\H&L04
MX(>0C;J4:V&ESO\ F"Y37B^WNIDK;Q=:@XR5%1*<7<] Y@!J4  :AR+'D3*%
M)\+OM_FW(W<$PTL"8&>KJ".]BA7NFZ3@HUL-+3D7*\1:GH09KG=)% GN%=(!
MU]7/AZJ0C9C@J@*-2CDSV"H:*WYJM!>MR3F)EQ-)6[N&Y)AK,,P 251S8,.Z
M5=+OEK,5NEM&8+!5R4-YM<W?PSQ'!ACL92,&5AJ92&&H\BR9XR=7? ,PV";K
M:5FQZJ>-M4U-4*.^BF7N7'XQK TM6>,N,8#4#X/?++(P,]NKXP.OI9<.=2<5
M;8RE6&H\GBM\=H/LRD[/P8^Z-K\77D<%/K&^>+TW9<S??*N\5I/1XC?J+-]G
M0\C)GU5?/$SR:^[W.H6DM]LIY*JMJ7. 2*)2S,?Q#2\9LKPT?\QDW;=2-_\
MQZ./N8(O3"ZVZ6)]%<WYCI=[)]FGPH:20=S<JN(XX$'488B.ZYF;N=@;3 #
M#8.P)GNRTIDOF5XB+K%$I+U-MUL^H;6@.+CV.\.C0%3B",01SCD6[,U-ORT(
M_=;_ $*G^(H9".L&'.T9&^G;&'/I1W.W5*5E!<(4J**JC.*212*&1E/00<>1
M<OBLWN#H?;O[H\CB_P#7]N\1'(CX(T-/5V?+&7(Z:ZW]YXWA-XJIEWZ<Q[P'
M64U/TC4TN/\ ICE*TD:NR:T8@$J>D'FT$>5^)>:+%$-D%-=*DQ#M=5([I_\
M;H$BXN72I"@C>JZ:AG;7TEZ?0QS<7+K3*1@6HZ>AIV_ZDIP=!)G3.=\S81LC
MNM?/4Q#THG<QC\2Z    #  ; !R'D<[J("SMT ;=(KK?:1J7.7$5XKU?:>0
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D%$%P$,8@B50ZQ* JAR1@-8.BHBA$0!411@ !J  &P#_RV?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>exelixis_logoxrgbx2023.jpg
<TEXT>
begin 644 exelixis_logoxrgbx2023.jpg
M_]C_X0TO17AI9@  34T *@    @ # $   ,    !#.0   $!  ,    !"?8
M  $"  ,    #    G@$&  ,    !  (   $2  ,    !  $   $5  ,    !
M  ,   $:  4    !    I $;  4    !    K $H  ,    !  (   $Q  (
M   A    M $R  (    4    U8=I  0    !    [    20 "  (  @ "OR
M   G$  *_(   "<0061O8F4@4&AO=&]S:&]P(#(S+C0@*$UA8VEN=&]S:"D
M,C R,CHP-SHR-2 Q.#HQ,#HR-@      !)    <    $,#(S,: !  ,    !
M  $  * "  0    !   $L* #  0    !   !1P         & 0,  P    $
M!@   1H !0    $   %R 1L !0    $   %Z 2@  P    $  @   @$ !
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MDI__V?_M%2I0:&]T;W-H;W @,RXP #A"24T$!       *AP!6@ #&R5'' (
M  (  !P"!0 617AE;&EX:7-?3&]G;U]21T)?,C R,CA"24T$)0      $.Z*
M+VTF;HFD<OR1I?7(F<@X0DE-!#H      0L    0     0      "W!R:6YT
M3W5T<'5T    !0    !0<W138F]O; $     26YT965N=6T     26YT90
M  !#;')M    #W!R:6YT4VEX=&5E;D)I=&)O;VP     "W!R:6YT97).86UE
M5$585    !0 0P!A &X ;P!N "  :0!8 #8 .  P #  ( !S &4 <@!I &4
M<P      #W!R:6YT4')O;V93971U<$]B:F,    , %  <@!O &\ 9@ @ %,
M90!T '4 <       "G!R;V]F4V5T=7     !     $)L=&YE;G5M    #&)U
M:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[      (M    $     $
M     !)P<FEN=$]U='!U=$]P=&EO;G,    7     $-P=&YB;V]L      !#
M;&)R8F]O;       4F=S36)O;VP      $-R;D-B;V]L      !#;G1#8F]O
M;       3&)L<V)O;VP      $YG='9B;V]L      !%;6Q$8F]O;
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M=%5N=$8C4FQT                5&]P(%5N=$8C4FQT
M4V-L(%5N=$8C4')C0%D            08W)O<%=H96Y0<FEN=&EN9V)O;VP
M    #F-R;W!296-T0F]T=&]M;&]N9P         ,8W)O<%)E8W1,969T;&]N
M9P         -8W)O<%)E8W12:6=H=&QO;F<         "V-R;W!296-T5&]P
M;&]N9P      .$))30/M       0 $@    !  $ 2     $  3A"24T$)@
M    #@             _@   .$))300-       $    'CA"24T$&0
M!    !XX0DE- _,       D           $ .$))32<0       *  $
M     3A"24T#]0      2  O9F8  0!L9F8 !@       0 O9F8  0"AF9H
M!@       0 R     0!:    !@       0 U     0 M    !@       3A"
M24T#^       <   _____________________________P/H     /______
M______________________\#Z     #_____________________________
M ^@     _____________________________P/H   X0DE-! @      !
M   !   "0    D      .$))301$       0     @   D    )      #A"
M24T$'@      !      X0DE-!!H      V$    &              %'   $
ML    !8 10!X &4 ; !I '@ :0!S %\ 3 !O &< ;P!? %( 1P!" %\ ,@ P
M #( ,@    $                          0             $L    4<
M                     0                         0     0
M &YU;&P    "    !F)O=6YD<T]B:F,    !        4F-T,0    0
M5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M;&]N9P   4<
M    4F=H=&QO;F<   2P    !G-L:6-E<U9L3',    !3V)J8P    $
M  5S;&EC90   !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG
M          9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N
M97)A=&5D     %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B
M;W5N9'-/8FIC     0       %)C=#$    $     %1O<"!L;VYG
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M=71S971L;VYG          MR:6=H=$]U='-E=&QO;F<      #A"24T$*
M    #     (_\        #A"24T$%       !     $X0DE-! P     "\$
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M!0$! 0$! 0         #  $"! 4&!P@)"@L!  $% 0$! 0$!          $
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M    % !! &0 ;P!B &4 ( !0 &@ ;P!T &\ <P!H &\ <  @ #( ,  R #(
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M1T(                  /;6  $     TRU(4" @
M                                           18W!R=    5     S
M9&5S8P   80   !L=W1P=    ?     48FMP=    @0    4<EA96@   A@
M   49UA96@   BP    48EA96@   D     49&UN9    E0   !P9&UD9
M L0   "(=G5E9    TP   "&=FEE=P   ]0    D;'5M:0   _@    4;65A
M<P  ! P    D=&5C:   !#     ,<E120P  !#P   @,9U120P  !#P   @,
M8E120P  !#P   @,=&5X=     !#;W!Y<FEG:'0@*&,I(#$Y.3@@2&5W;&5T
M="U086-K87)D($-O;7!A;GD  &1E<V,         $G-21T(@245#-C$Y-C8M
M,BXQ               2<U)'0B!)14,V,3DV-BTR+C$
M                                                 %A96B
M  #S40 !     1;,6%E:(                     !865H@        ;Z(
M #CU   #D%A96B        !BF0  MX4  !C:6%E:(        "2@   /A
MML]D97-C         !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M                                9&5S8P         N245#(#8Q.38V
M+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@+2!S4D="
M   N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@+2!S
M4D="                             &1E<V,         +%)E9F5R96YC
M92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$
M "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@245#-C$Y-C8M,BXQ
M                                  !V:65W       3I/X %%\N !#/
M%  #[<P !!,+  -<G@    %865H@      !,"58 4    %<?YVUE87,
M     0                        */     G-I9R      0U)4(&-U<G8
M       $      4 "@ / !0 &0 > ", *  M #( -P [ $  10!* $\ 5 !9
M %X 8P!H &T <@!W 'P @0"& (L D "5 )H GP"D *D K@"R +< O #! ,8
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M^!GXJ/DX^<?Z5_KG^W?\!_R8_2G]NOY+_MS_;?___^X (4%D;V)E &1
M 0, $ ," P8               #_VP"$  (" @(" @(" @(# @(" P0# @(#
M! 4$! 0$! 4&!04%!04%!@8'!P@'!P8)"0H*"0D,# P,# P,# P,# P,# P!
M P,#!00%"08&"0T*"0H-#PX.#@X/#PP,# P,#P\,# P,# P/# P,# P,# P,
M# P,# P,# P,# P,# P,# P,#/_" !$( 4<$L ,!$0 "$0$#$0'_Q $/  $
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M P$! A$#$0   +_
M
M
M                                         #%O'^1Z4Y4Y!QL
M
M#X8^^+]SBOS_ *<F?>X_N],@   !T#X_VZT.BO0-K_H?S3O]L0
M                                                      !COXOW
M:W^D.^\4\>Y)JF.?_9^*?_<72<FN=]>@  #A_P WZJI///I2:7:/4TH>?==
M
M    #C\=ZB_.'I[I?R_J@#7,6F^@/.6:.4<3  &B)K-Z)]!]2^=].U_T/YIU
MS
M       C-P3L&N'I'OGX  28YUP"R#N_H0  0:ZG[BA7U=VS:5W]YSS?ROB
M
M     $,^L.UX)]2]Q@ #,_)^*VH^@O-X $:N#<_K=Z/[\D)S/@]F?>WGP
M
M   1[X9SBLOHGT&0 !*OL+KBPWN?HP 8LX_R.JOS[Z1VF6EM_HWS)D/[7P@
M
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M@  11M6ORU(I6C&J/S/LNPPSG$ROK:>=;YUB0!C:8K0O3M4.()YUOG*)
M%'&F4);5      VAZ@L=^U I0TR@;:H L4K>XW/0  #045:Y0VFH M I>V&F
M@%0&F=;MJ      #T69;9UB0(CVK0IIEJ!E5/I,QV     J?OG5_>GP$MHM?
M7EJ!7]TYW=$GKGLSX 2'YIP>S'O7SZ /QK?\*7WNN( %?737=\3.N^R_I.GM
MKIV9W9_4X \]VN,;Y@"VBFEG-+@ =3*5=<H9374   #X3-K:X&FF5(D59WIW
MX_8Z@<2BTVF@    \UFV.,4      =@/3OCON@<.>>W7'!$P!I+K<])[5N
M*NKTJBOG] )91:^G+7]@#SZ:XQIF      /U/33COW, JWOG5->@&54^DS'8
M    "@77*+$U EM%KZ\M0.'_ #?JJ(\W^H.K?/\ H ?$V6=Y] 2-YMP,   "
M)O779E?'3?=_U'=?J?*MW](>7]YKD!M#RT;8?0"VBFEG-+@#B#S[ZXQ]F
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M"VBFEG-+@8<F/-]KCK +#ZWN0STU             \TVV.-T 6KTO:530
M    #IB/._KEC&8 _0_, &?HGT&Y;<L   >?+7&-<P!8M6]Q>>@      JUO
MG51>@&54^DS'8    "@/7*+4U EM%KZ\M0 !MJ:5+^=/3../B?= )GQV_P!+
M3 [*ZM$+>KNV8,]3]Q$#<WI;CZ.\Q]^^Q\0  ; \M6V&L MHII9S2X'#'E[V
MP_, ^&?XF>M;R[K;.$3K           /--MCC= $Q*VEY%@  !VR)GK6P
M$=)CS]:X\<  #M9Z'LMLL1(   \^6N,:Y@"3\6G#6P   W4+%ZW  JUOG51>
M@&54^DS'8    "@/7*+4U EM%KZ\M0  ,+<6Y;5CY_\ 1WQ '*_H_/;KZ/\
M,.*N/\DK-Z)]!:( 2][)ZPGWW!TH  !L#RU;8:P"VBFEG-+@"B33*'-J@ #0
M=R)/UM+F+37K;(<2         /--MCC=      S/$^CK+8    5Z7I3/?/4
M#47NYZS"K8   #SY:XQKF     !S!ZB<=P *M;YU47H!E5/I,QV     H#UR
MBU-0);1:^O+4   5X=+]Z16Z^[& &;N5<1Q3Q[DO#_F_2!S7ZORV_P#I/RYS
M_P"S\0  &P/+5MAK +:*:6<TN ,,3'GKUQZR    :R:-;6P4TS;$@
M#S3;8XW0     ,\Q/HHRV    'YGF^UQQ', "4T6O[RU    'GRUQC7,
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M2J:        8IF//!KCU, Y(V1^0!E)/H?RU[A$@  >?+7&-<P!8M6]Q>>@
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M->0?L_# P=Q/F%7'07HL@#G/U_DMV]'^8.S?O^> !L#RU;8:P"VBFEG-+@
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M*GO/'I;9Y: ;O3.VOT7YER%]KX8V!Y:ML-8-9Z$<MI&Q( ZV53Z9UUVIQP
M !^Y976]L^>FX        *6=,^F3     'TR?$VB4OD6)$/[5KFO0 97B;?\
M]-8   /Q*YKTBG-=C(:2U//21$2*CM,\+S      [Y"SRFF88D 07M2!UZ@
M  #L$+%:WE)6P%36F>"YC<0E)%K**7_4 K^Z<[MB1USV;N;UM'[^\YYHY1Q,
M     8FX[R:(?6W:'7_Q_M S5RGB4R^SNJ1M"B_7+4<O"?5;S(K8  #I$Q!>
MU8BS6/MHQZC9&HY\S=$RVK:P2M\PQ(
M                    Q[\;[E2'G+TYMZ7L)[EZ/EAV)UH
M    !MSB#]CF#Z
M      5H=%^@8[\*YS++L7K2P7N3I
M                                          86XORVJ_S]Z.S5RCB=
MH_?WG/<7H
M                    !IB:I?/7I/JWS_I6P>B/-/9?W?/
M                                                           $
M9^"=@UW]+]Z6I^@O-V5>0\;
M                                   &USTJ(\W^H9U=M=-27YUU^
M
M         !#?K+M7KWXOW3I[:Z<
M                                        &!.(<TSSR[AFJ8
M
M
M                                                       __]H
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MC3+QB;C/,:P5*@C&,8<90ED55\!0*%0D++*BX*3& ("&F?3 PMW8#!G,'Z>
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M5U0ZG%827+'Q%YH3\@^].,B"L'2HMR^(^)H'R%#/LW4&ZAG,._@0XUAQ -V
M-LIAWSE'*(;Y2\:QN<2:I^<"\8FXR5$6NI<);0'BQ$P\.[AW>@( (38ABE1F
M2GJ[MHGR .S .^L8VW@@XU1';(4-LIAT2FRF#?(7C5$=LI-41WQ+QB<<BE'N
MX"&BXMY%OF34Y\HQ".E.4R&TIB12*T&^<O'#S%R^.Y.@+!%6$SF'<<H&U!-X
M,#!MV!NP-V!NP-V!NP-V!NP-V!NP-V!NP,)V$=\2[ W8&[ W8&[ PFTP.W8&
M[ W8&[ P[8@8-NP-V!NP-V!NP-V!NP-V!NP-V!NP-V!NX,([Y2CLW8&[ W8&
M[ W8&[ W8&[ W8&[ W8&$V^0#!MV!NP,)\M05K_._9V[.]/*TND2(?4798A%
M<(JG4>['Z"5F^@E9OH)6:4T%628K'L#=@;L#";?0 =F [ 8&WR]@83L(B/\
MN=?5RI<&=X=X81V:2)7&#)_HV_\ NR>%OW^,:1Y8]Z/[$IN6_A<$ ;-*TN&6
M'[MV5V7V(B.S32M"J1J.DOE2)34YRGP_L2GM;]RA(:&>1#R6T!VCPWL2>O2N
MB+:J=4C),ECX<Z]B=1%K_&ZD66.X^Q0),@WD6   ?\:__]H " $#  $% /\
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M/WPXCO@N*Q$J"?OSOWF@3,8=]4!V8H[X?_1^!W "A^AN=(>=4I=LHANPAME
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M[F:WJ:?+\:$_?'3O7_)W&QC\F\T9"0T?"55IY%4SG+):S4[XJE87*5H-!E
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MR401)^UI-@%YHV\,(+8HZJ"P:[SF3H+N\@19CQ 7DX "LT7=Y-U;->[7L?P
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M0?=IE7*%1ZK#FMQ7Y$T>1-$'0D$9C[5>0VHB2E;M^"+VF]0KUJDL!54  "P
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M7L@Y9H\O4"*.ODA3&HJ7&V2IJ&QDF<\[.Q/XN0]NS?E>U9GHI%*&FN=)#5*
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M%;*2NJ9*(PPO*&(>0),S8#=YACV*2T%HK=G*Q=969(S Z_P]45P:"8C68)P
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M@RL#@58'80=1'(M69[))U=SL\XF@4DA94V20OAZB5"5/IX\VEHS19I-^BNT
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M0\C)GU5?/$SR:^[W.H6DM]LIY*JMJ7. 2*)2S,?Q#2\9LKPT?\QDW;=2-_\
MQZ./N8(O3"ZVZ6)]%<WYCI=[)]FGPH:20=S<JN(XX$'488B.ZYF;N=@;3 #
M#8.P)GNRTIDOF5XB+K%$I+U-MUL^H;6@.+CV.\.C0%3B",01SCD6[,U-ORT(
M_=;_ $*G^(H9".L&'.T9&^G;&'/I1W.W5*5E!<(4J**JC.*212*&1E/00<>1
M<OBLWN#H?;O[H\CB_P#7]N\1'(CX(T-/5V?+&7(Z:ZW]YXWA-XJIEWZ<Q[P'
M64U/TC4TN/\ ICE*TD:NR:T8@$J>D'FT$>5^)>:+%$-D%-=*DQ#M=5([I_\
M;H$BXN72I"@C>JZ:AG;7TEZ?0QS<7+K3*1@6HZ>AIV_ZDIP=!)G3.=\S81LC
MNM?/4Q#THG<QC\2Z    #  ; !R'D<[J("SMT ;=(KK?:1J7.7$5XKU?:>0
M24M/N84-(VLX&.)MYQS.[#F_ >+GWTOOC\W9JM54L[PNJ*-I8J0 /3.F5:6=
M=R>FL]#%,NS!DIT5AK[8]&]YXS?7BWV*Q0&:H<=U)*YU1P0IB-^25R$11M)T
MNV?,SNT4E5^[V&RA]Z*V6Y&)AI(^8G7O2,._<D[,,/1IZ2BI9JZMK)HZ>AH:
M=#)-//*P2.*)!K9G8@ #GT-QS!!!4<3,W11S9IK4P<4<0[J*VP2>LBQQD(U/
M)BVL!<.4_%'(MM$O$+*U+A>+; N$EZMD0+&, =]44X):+G9<8_68+(AWD<8J
M>1#?HFGK<FWLQ4N?,OQXMU],I(2KA39U]-O%E]<N\G.,+7F++]QAN]DO5-'6
M6JYTS;T4\$JAD=3VP>?6.?D<5OCM!]F4G9F9C@J@ECT :<&Z:JB,,\>4;5OQ
M-M&]3(P_*#R."GUC?/%Z;LMYJG!"5V<+DT((PQ6.&FB)!Y^Z4^CQ&_46;[.A
MY&59(T+)1V6]RU# 8A5-.L8)Z,6<#DT?#2UU'O\ 7B.OS04/>TRMC3T[8'_-
M==]@?4J/7>BMO424N7+8R2YFNR:BD1UK3Q-LZV7#5ZU<6Z,:*T6FDCH+;;H4
MIZ&CA&ZD<:#!5 ["R.H='!5T88@@ZB"#TZ5$-' 4ROF O6Y<D .[%B<9J3'I
MB8]S[ KT'DS<,+Q4]X)*O*$CGU'?U%(/:DF1!T;PYN1<OBLWN#H?;O[H\CBY
M.4(ADS%0I'(=A9*%2P'I;PY M&9(3;K[;E=\L9OI44UEOF8<V. DB8X=9$QW
M6'0P5A_(,]VKJH*F1EL69Z0,]LN:+ZJ"4CN7PUM$^#KVUP8]EMG%G/-N,7#F
MPU J<L6VI35?:Z%L4FW&VTD#C'$C"1P ,55L?P'BY]]+[X_-V:QV?X*[Y4RS
M44]YSS7[(XZ2"0214V]_J54B! NW=WVV+Z,U54S1TU-3(TM142L$2-$!9F9F
MP   Q).S1;3E^J=.%V3ZEQEN%<5%SJUQ1[G*IP)4C%8 =B$MJ+ZO1+,0JJ,6
M8Z@ .<G2AX[Y]MI6LJXBW#.R5*8-3T\@P-UD1MDDRDB$$=S&=_:XP[!7<9<A
MVLC)E[F,N>K52IBEJKI3KKE1>]IZAC[Y@,$D[K4K]SCS'8>13<)<ZUX3(.:*
MS#+-RG;!+/<ZAO\ "9SJ6GJG//J20XZ@[8>CQ6^.T'V92=FL/#ZRQ.4N,@GS
M'<%7%*"U1L/A53(=@[GN(P>^<J!I06JWPBGH+9314E%3KLCAA0)&H])0!R."
MGUC?/%Z;LEKL%@M\MVOU]JHZ&RVJ ;TE14RG!$4#8.=CL506.H:9.R DJU-7
M9:/>O%:FR>OJ&:>KD':,KMN^QP]'B-^HLWV=#Z))U ;3IF#C3?:1Z7_=5,MI
MR1#*N#/;4D$M16;I&(6>555#SJF]L8<B\YHNS[M#9J9IY$'?2,-4<2;>ZD<A
M1VSI=LQWB3K+G>ZIZJK(.*J6U+&OL8U 1>T/0MV5\OQ"2X5[8R3N"8J:!2.L
MJ)B-BH#Z9."C6=*#+-DC/44H+U=8X'6U50^'6SRD;6<C\0P U =CN%@D*0W.
M+]ZL%>P_P*R,'JR3MW7Q*/[$GM:5UGN]');KM;)6@N%!*,'BD7F[8.U2-1&L
M<BANMKJ6HKG;)XZJWU:;8YHCO(WI8ZB.<8C2V9EIE6&KD!I[S0 XFFK(L!+'
MKYL>Z4\ZD'T;E\5F]P=#[=_='T:>FI:>6KJZR6.GHJ*!3)-//*P2.*)!K9W8
M@*!M.EBRS=U09HNLLM[S8(R&6.NK=TF -SB"-4BQV$J2-O)K\KYQL5'F.P7)
M-RLM=;&)(VPV,.=67:K*0RG6"#I57W@C<3F2T8M(V1KM,J7" ;=VDK7P2=1S
M+-NM[-CI46#,MGK<NWVD.%39KG ]+4IAS]7( 6'LEQ!YCV*CM=NI)[E=+C((
M;?:Z.)YZFHD8X!(H8PSN?2&E#F_CS3_R^U1E)[?PTCD#3U/JE-UFC)")TP1D
MD[)&&M#3T5%314='1Q)!24D"+'%%%& J(B* %50   , /P+B!F2TV>Q26K,.
M9+I<[7)+=DCD:GJJJ26(NG5'=)5AB,=6GT+E[RRG@M/H7+WEE/!:?0N7O+*>
M"T^A<O>64\%I]"Y>\LIX+3Z%R]Y93P6GT+E[RRG@M/H7+WEE/!:?0N7O+*>"
MT^A<O>64\%I]"Y>\LIX+0 V;+R@G L;RN [9PAT@FXC9TM.6;0&QJ:*QB2X5
M[J#WJRSQPPQ[P]5NOAT:092R%94M-LC;KJR=F,M565! #U%5.W=2R-AK)V#4
MH"@#T:7AUPDMUN@RW>T,F>;Y5W):.HGB5L$MT*;C$))AO2MZI<$&HMI@+)EX
M ;!_.4\#I]"Y>\LIX+3Z%R]Y93P6GT+E[RRG@M+9<.-%':H,C67"MJ+10UPJ
MY+I41L##2R@(NY#CW4G.P&YL8D)%$BQ11*$CC0!555&   U  =AGI*N".JI:
MJ-H:FFF4/')&X*NCHP(96!P(.HC2KO?"7, X?UE2S2296K(6J[/OL<3U&ZRS
M4PVG=4N@]2BC22.E@RO=8U;=2H@NKQAQZ[=FID(]+3Z%R]Y93P6GT+E[RRG@
MM&1['EYD<8,IO*:P?_2TCREQOHJ*2[Y9,=+8,RTE>M:]PH OO8JL%4K-#AN%
MM>^-UN^WO1S[G?*MJLT^7[_4TDMLFJ;FL$K+#0T\#[\9C;=[N-N?9I]"Y>\L
MIX+3Z%R]Y93P6GT+E[RRG@M/H7+WEE/!:?0N7O+*>"T^A<O>64\%I]"Y>\LI
MX+3Z%R]Y93P6GT+E[RRG@M/H7+WEE/!:?0N7O+*>"T^A,O>64\%I%_O/-F7\
MHVH-A4-;S-=*QE__ %HR4\2GMLQ](Z26+)%M9*BO9);]F&L837"XS("%>HFP
M&I02%10J*.]48G'D<-(>'M%;ZQ\L5ESFNXKZP4@5*J&!(MS%&WL2AQZ-/H7+
MWEE/!:?0N7O+*>"T^A<O>64\%I]"Y>\LIX+3Z%R]Y93P6GT+E[RRG@M/H7+W
MEE/!:?0N7O+*>"T^A<O>64\%I]"Y>\LIX+2..]7'*V6*,X&:K>LGKI%&.L+#
M#"@8X=,@';T-ZI'ES9GRHA:"JSG<8T5XHW[^*B@7%:=&V-@2[>J<C5R,Y9YR
MC:[-49=O45N2@FJ[FM/,334<<,F]$8VPP=3AKUZ?0N7O+*>"T"2V_+5&I(!E
MENY90#M.$=.YU>EI27SC%F*'.LM(XDBR?;8W@M+.IQ7X5+)[]4+[#!%/J@PU
M:0TM+#'34U-&L5/3Q*$2-$&ZJJJX   8 #D4G#RV3AK;E\I69@9#B)*YUQAA
M)!V0HV\1ZYAZWT*2W6ZDDK[C<)DIZ"AA&])--(<$11TD_DV[- M2L=5FR\*D
MN8KDNL!@,5IHCS1Q8X#UQQ8[=79%ENU.]NOM.G5T68Z+!*E%YDDQ!65,=>ZX
M.',1H_\ ([O:+_2[QZII'DHI]WFWD99$Q])]/HVU>4%_0T^C;5Y07]#3Z-M7
ME!?T-)'N-!;Y,J7U.JOU/%7J[QR1@F&IC3=&+*>Y8<ZGM#T:R", R3021Q@G
M ;S*0->A!LF7N^8_3*<Y)_TM/H7+WEE/!:1Q7&;*V7Z=C[Y5S7&:I*#M1P4Y
MWO\ J&E-FR[5CY\S_3J?@E\K(5BI+>S#!C04F+A&YNM=F?#85!([!_*,^Y1M
MF:J$ B)*^G61XB=9,,NJ2,]M&!TGJ^'&<KKDRH;>:.TW$"[4&\3B%5G:.H1?
M3D;25[5:K/GJCB!;K[/7K#,PZ/@]:(#CV@QT;_</"K-EK13@9C:JB>/\4E.L
MJ'TP<-#'6T5712+WT=33RPL/3$BJ=,&J8U(VJ6 /Y#IA'*)3LP3NO^&.B163
M*U[O,DAPC6AMM748GTXXF']^B+0\+;C9X'P)K;_)#:XP.DK,_6G\49T@J^*7
M$.*B@#*TUBRQ"7D9?5(U=5J IYL5@/IZ&/(64:6VW"6,1UN89\:JYU  P/6U
M<Q:0@^M!"]K_ ,3W;,T^[+5Q**>ST9_SZV;%88_2Q[IO8@Z55?7U#5=?7S25
M-=5N<6EFE8O(Y]-B="S' #63I'GS--)U>9KI"19K=*.ZMU)(-K#FFF'?>M7N
M=N]_\&ZNJIHJF/UDJ*X_(P.A>3+5JD=N^=J. D^F2F@-+8K=3$'$&*EB37LQ
M[E1H !@!L _\5?R&W3]9E_)CR4T3*<4GKV[FHEU;1'AU:_\ -T^A2\0\STF]
ME^WR;^6;?*.YK:F,X?"7!VQ1,.X&QFU[%U_V)5=10S"/,=\)M^7E]4DKK[Y/
MAB-4*8MZ>Z.?0#$L>=V.)).LDGG).LZ,U:LD&3K+(K7^L7%3.^IEHHF]<XUN
M1WJ]MAI345' E+24<20TM-$H5(XXP%1%4:@ !@!_8DSNP5%!+,3@ !M).E=<
M*:8OE^S;UNRXGJ6A1O?:C#5KF<8@^M"Z4F6;&O5O*.MN=R9=Z.BI0<'G?I/,
MB^J;5TZ6[+5@IA36ZW1[JXZWED.N2:5MK.[8LQZ>U_8F,KVRH,>8,Y))3[R'
M!Z>@754RZM8+@]6OID\VENL5DHVK;I<YEIK=11ZMYSTG8JJ!BQ.H $Z+:X72
MMO=>5J,Q7@+@:BHPP"ICK$<8.Z@/-K.LG^Q.KN-?.E+0T$+U%94N<%CBC4L[
M$]  QTN^:JA9!!62"GLE%@6:*CC.[3Q*HVLV.\0-K-I_NG,=*/\ >EZA $+C
M$VVE? BG7HD;493TX*-0U_V)T?#FV5 6JO2K6YE=6_PZ%&][A8\W7.N)!]2I
MZ=*/B9FJD_=XFZS)MKF7OS_[^13S?Z0/M_6_V*W/.V;:NNSE=KC6&J6DN#HM
D%$%P$,8@B50ZQ* JAR1@-8.BHBA$0!411@ !J  &P#_RV?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139772658745424">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th"><div>May 09, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May  09,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">EXELIXIS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000939767<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock $.001 Par Value per Share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">EXEL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-30235<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">04-3257395<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1851 Harbor Bay Parkway<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Alameda<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94502<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">650<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">837-7000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>exel-20230509_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="exel-20230509.xsd" xlink:type="simple"/>
    <context id="i17e417b11a954ed38a4e548f5772d460_D20230509-20230509">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000939767</identifier>
        </entity>
        <period>
            <startDate>2023-05-09</startDate>
            <endDate>2023-05-09</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="i17e417b11a954ed38a4e548f5772d460_D20230509-20230509"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhZTc2MzU5MGY2ZjRhNmY5NTdjNWYwMDU2MmVhMzdhL3NlYzozYWU3NjM1OTBmNmY0YTZmOTU3YzVmMDA1NjJlYTM3YV80L2ZyYWc6ZTU3MWQyYTEwZDFkNDdlMzgzMGU2YjljNTYzYjllNjYvdGFibGU6YzE1NTM3YThlMTk2NDMxYTgxYzYzNzI4ZGViN2Y5Y2IvdGFibGVyYW5nZTpjMTU1MzdhOGUxOTY0MzFhODFjNjM3MjhkZWI3ZjljYl8yLTEtMS0xLTExMDk0MQ_d882c735-b4c6-4243-9eb5-eecccfafd49c">0000939767</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i17e417b11a954ed38a4e548f5772d460_D20230509-20230509"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhZTc2MzU5MGY2ZjRhNmY5NTdjNWYwMDU2MmVhMzdhL3NlYzozYWU3NjM1OTBmNmY0YTZmOTU3YzVmMDA1NjJlYTM3YV80L2ZyYWc6ZTU3MWQyYTEwZDFkNDdlMzgzMGU2YjljNTYzYjllNjYvdGFibGU6YzE1NTM3YThlMTk2NDMxYTgxYzYzNzI4ZGViN2Y5Y2IvdGFibGVyYW5nZTpjMTU1MzdhOGUxOTY0MzFhODFjNjM3MjhkZWI3ZjljYl81LTEtMS0xLTExMDk0MQ_ddc3966d-1ca6-4b05-b915-79e7a9039722">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="i17e417b11a954ed38a4e548f5772d460_D20230509-20230509"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhZTc2MzU5MGY2ZjRhNmY5NTdjNWYwMDU2MmVhMzdhL3NlYzozYWU3NjM1OTBmNmY0YTZmOTU3YzVmMDA1NjJlYTM3YV8xL2ZyYWc6NWU0MGI3MjMyOTVmNDhlYWIxZGY1M2ExMzZhMmVlNWEvdGFibGU6NzRkYzE2MmQxYTk0NGVhMWI5MmFjYjQ4NDE3N2YzMTIvdGFibGVyYW5nZTo3NGRjMTYyZDFhOTQ0ZWExYjkyYWNiNDg0MTc3ZjMxMl8wLTEtMS0xLTExMDk0MQ_a1eadae9-6c1f-4542-8262-8109dc8b0c96">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="i17e417b11a954ed38a4e548f5772d460_D20230509-20230509"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhZTc2MzU5MGY2ZjRhNmY5NTdjNWYwMDU2MmVhMzdhL3NlYzozYWU3NjM1OTBmNmY0YTZmOTU3YzVmMDA1NjJlYTM3YV8xL2ZyYWc6NWU0MGI3MjMyOTVmNDhlYWIxZGY1M2ExMzZhMmVlNWEvdGV4dHJlZ2lvbjo1ZTQwYjcyMzI5NWY0OGVhYjFkZjUzYTEzNmEyZWU1YV8yMjA_9cae6a51-7773-4a59-8490-10b56bbffaac">2023-05-09</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="i17e417b11a954ed38a4e548f5772d460_D20230509-20230509"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhZTc2MzU5MGY2ZjRhNmY5NTdjNWYwMDU2MmVhMzdhL3NlYzozYWU3NjM1OTBmNmY0YTZmOTU3YzVmMDA1NjJlYTM3YV8xL2ZyYWc6NWU0MGI3MjMyOTVmNDhlYWIxZGY1M2ExMzZhMmVlNWEvdGFibGU6N2E2YTkwZjI0ODFhNDJjOWEyNTEyYjk2YTQ1NjM2ODIvdGFibGVyYW5nZTo3YTZhOTBmMjQ4MWE0MmM5YTI1MTJiOTZhNDU2MzY4Ml8xLTAtMS0xLTExMDk0MQ_b7c1378e-8833-43fa-9c7a-75a03292de27">EXELIXIS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i17e417b11a954ed38a4e548f5772d460_D20230509-20230509"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhZTc2MzU5MGY2ZjRhNmY5NTdjNWYwMDU2MmVhMzdhL3NlYzozYWU3NjM1OTBmNmY0YTZmOTU3YzVmMDA1NjJlYTM3YV8xL2ZyYWc6NWU0MGI3MjMyOTVmNDhlYWIxZGY1M2ExMzZhMmVlNWEvdGFibGU6MGQ1MjE5OTExNDlhNDJhZTk5YmRiNTkzNGIwM2ZjOTAvdGFibGVyYW5nZTowZDUyMTk5MTE0OWE0MmFlOTliZGI1OTM0YjAzZmM5MF8wLTAtMS0xLTExMDk0MQ_a8d60ba3-49d3-474a-8293-7cf07dcf9743">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="i17e417b11a954ed38a4e548f5772d460_D20230509-20230509"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhZTc2MzU5MGY2ZjRhNmY5NTdjNWYwMDU2MmVhMzdhL3NlYzozYWU3NjM1OTBmNmY0YTZmOTU3YzVmMDA1NjJlYTM3YV8xL2ZyYWc6NWU0MGI3MjMyOTVmNDhlYWIxZGY1M2ExMzZhMmVlNWEvdGFibGU6MGQ1MjE5OTExNDlhNDJhZTk5YmRiNTkzNGIwM2ZjOTAvdGFibGVyYW5nZTowZDUyMTk5MTE0OWE0MmFlOTliZGI1OTM0YjAzZmM5MF8wLTEtMS0xLTExMDk0MQ_09879d9b-3685-462b-a4c7-fcef8dd8b28b">000-30235</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="i17e417b11a954ed38a4e548f5772d460_D20230509-20230509"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhZTc2MzU5MGY2ZjRhNmY5NTdjNWYwMDU2MmVhMzdhL3NlYzozYWU3NjM1OTBmNmY0YTZmOTU3YzVmMDA1NjJlYTM3YV8xL2ZyYWc6NWU0MGI3MjMyOTVmNDhlYWIxZGY1M2ExMzZhMmVlNWEvdGFibGU6MGQ1MjE5OTExNDlhNDJhZTk5YmRiNTkzNGIwM2ZjOTAvdGFibGVyYW5nZTowZDUyMTk5MTE0OWE0MmFlOTliZGI1OTM0YjAzZmM5MF8wLTItMS0xLTExMDk0MQ_c9346528-1905-4def-9a5f-236695fe0789">04-3257395</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i17e417b11a954ed38a4e548f5772d460_D20230509-20230509"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhZTc2MzU5MGY2ZjRhNmY5NTdjNWYwMDU2MmVhMzdhL3NlYzozYWU3NjM1OTBmNmY0YTZmOTU3YzVmMDA1NjJlYTM3YV8xL2ZyYWc6NWU0MGI3MjMyOTVmNDhlYWIxZGY1M2ExMzZhMmVlNWEvdGV4dHJlZ2lvbjo1ZTQwYjcyMzI5NWY0OGVhYjFkZjUzYTEzNmEyZWU1YV8xNTk2_a3932620-4732-443a-85e8-66c095025e0d">1851 Harbor Bay Parkway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i17e417b11a954ed38a4e548f5772d460_D20230509-20230509"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhZTc2MzU5MGY2ZjRhNmY5NTdjNWYwMDU2MmVhMzdhL3NlYzozYWU3NjM1OTBmNmY0YTZmOTU3YzVmMDA1NjJlYTM3YV8xL2ZyYWc6NWU0MGI3MjMyOTVmNDhlYWIxZGY1M2ExMzZhMmVlNWEvdGV4dHJlZ2lvbjo1ZTQwYjcyMzI5NWY0OGVhYjFkZjUzYTEzNmEyZWU1YV8xNTk3_bfd61836-9467-4e23-af65-3f5c773b7747">Alameda</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i17e417b11a954ed38a4e548f5772d460_D20230509-20230509"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhZTc2MzU5MGY2ZjRhNmY5NTdjNWYwMDU2MmVhMzdhL3NlYzozYWU3NjM1OTBmNmY0YTZmOTU3YzVmMDA1NjJlYTM3YV8xL2ZyYWc6NWU0MGI3MjMyOTVmNDhlYWIxZGY1M2ExMzZhMmVlNWEvdGV4dHJlZ2lvbjo1ZTQwYjcyMzI5NWY0OGVhYjFkZjUzYTEzNmEyZWU1YV8xNTk4_e8cd1e3a-f4a0-4861-ab97-493bda1eb776">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i17e417b11a954ed38a4e548f5772d460_D20230509-20230509"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhZTc2MzU5MGY2ZjRhNmY5NTdjNWYwMDU2MmVhMzdhL3NlYzozYWU3NjM1OTBmNmY0YTZmOTU3YzVmMDA1NjJlYTM3YV8xL2ZyYWc6NWU0MGI3MjMyOTVmNDhlYWIxZGY1M2ExMzZhMmVlNWEvdGV4dHJlZ2lvbjo1ZTQwYjcyMzI5NWY0OGVhYjFkZjUzYTEzNmEyZWU1YV8xNTg5_2c749563-a8e9-4f73-af98-576d96688a93">94502</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i17e417b11a954ed38a4e548f5772d460_D20230509-20230509"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhZTc2MzU5MGY2ZjRhNmY5NTdjNWYwMDU2MmVhMzdhL3NlYzozYWU3NjM1OTBmNmY0YTZmOTU3YzVmMDA1NjJlYTM3YV8xL2ZyYWc6NWU0MGI3MjMyOTVmNDhlYWIxZGY1M2ExMzZhMmVlNWEvdGV4dHJlZ2lvbjo1ZTQwYjcyMzI5NWY0OGVhYjFkZjUzYTEzNmEyZWU1YV8xNTk5_20b960c7-8f18-4689-8cf7-986715c8127c">650</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i17e417b11a954ed38a4e548f5772d460_D20230509-20230509"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhZTc2MzU5MGY2ZjRhNmY5NTdjNWYwMDU2MmVhMzdhL3NlYzozYWU3NjM1OTBmNmY0YTZmOTU3YzVmMDA1NjJlYTM3YV8xL2ZyYWc6NWU0MGI3MjMyOTVmNDhlYWIxZGY1M2ExMzZhMmVlNWEvdGV4dHJlZ2lvbjo1ZTQwYjcyMzI5NWY0OGVhYjFkZjUzYTEzNmEyZWU1YV8xNTkw_185dedb8-d4a4-4038-b751-5421ff02a534">837-7000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="i17e417b11a954ed38a4e548f5772d460_D20230509-20230509"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhZTc2MzU5MGY2ZjRhNmY5NTdjNWYwMDU2MmVhMzdhL3NlYzozYWU3NjM1OTBmNmY0YTZmOTU3YzVmMDA1NjJlYTM3YV8xL2ZyYWc6NWU0MGI3MjMyOTVmNDhlYWIxZGY1M2ExMzZhMmVlNWEvdGV4dHJlZ2lvbjo1ZTQwYjcyMzI5NWY0OGVhYjFkZjUzYTEzNmEyZWU1YV8xNTky_d2e2313f-8a19-4ec3-800d-9db9d3f006ef">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="i17e417b11a954ed38a4e548f5772d460_D20230509-20230509"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhZTc2MzU5MGY2ZjRhNmY5NTdjNWYwMDU2MmVhMzdhL3NlYzozYWU3NjM1OTBmNmY0YTZmOTU3YzVmMDA1NjJlYTM3YV8xL2ZyYWc6NWU0MGI3MjMyOTVmNDhlYWIxZGY1M2ExMzZhMmVlNWEvdGV4dHJlZ2lvbjo1ZTQwYjcyMzI5NWY0OGVhYjFkZjUzYTEzNmEyZWU1YV8xNTkz_83b11890-907c-465a-8a61-0681178f2b94">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="i17e417b11a954ed38a4e548f5772d460_D20230509-20230509"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhZTc2MzU5MGY2ZjRhNmY5NTdjNWYwMDU2MmVhMzdhL3NlYzozYWU3NjM1OTBmNmY0YTZmOTU3YzVmMDA1NjJlYTM3YV8xL2ZyYWc6NWU0MGI3MjMyOTVmNDhlYWIxZGY1M2ExMzZhMmVlNWEvdGV4dHJlZ2lvbjo1ZTQwYjcyMzI5NWY0OGVhYjFkZjUzYTEzNmEyZWU1YV8xNTkx_3ea1e474-4b46-4061-9b62-d71f4ded5818">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="i17e417b11a954ed38a4e548f5772d460_D20230509-20230509"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhZTc2MzU5MGY2ZjRhNmY5NTdjNWYwMDU2MmVhMzdhL3NlYzozYWU3NjM1OTBmNmY0YTZmOTU3YzVmMDA1NjJlYTM3YV8xL2ZyYWc6NWU0MGI3MjMyOTVmNDhlYWIxZGY1M2ExMzZhMmVlNWEvdGV4dHJlZ2lvbjo1ZTQwYjcyMzI5NWY0OGVhYjFkZjUzYTEzNmEyZWU1YV8xNTk0_2802638e-f089-4bec-92cc-11f4bb3800da">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="i17e417b11a954ed38a4e548f5772d460_D20230509-20230509"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhZTc2MzU5MGY2ZjRhNmY5NTdjNWYwMDU2MmVhMzdhL3NlYzozYWU3NjM1OTBmNmY0YTZmOTU3YzVmMDA1NjJlYTM3YV8xL2ZyYWc6NWU0MGI3MjMyOTVmNDhlYWIxZGY1M2ExMzZhMmVlNWEvdGFibGU6NGQwYjE0NjkwODIzNDNhZmIzZjEwMjBiZmE0MDM0ZjgvdGFibGVyYW5nZTo0ZDBiMTQ2OTA4MjM0M2FmYjNmMTAyMGJmYTQwMzRmOF8xLTAtMS0xLTExMDk0MQ_9b57a22b-9b78-4ae8-b8ea-50049c62258b">Common Stock $.001 Par Value per Share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i17e417b11a954ed38a4e548f5772d460_D20230509-20230509"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhZTc2MzU5MGY2ZjRhNmY5NTdjNWYwMDU2MmVhMzdhL3NlYzozYWU3NjM1OTBmNmY0YTZmOTU3YzVmMDA1NjJlYTM3YV8xL2ZyYWc6NWU0MGI3MjMyOTVmNDhlYWIxZGY1M2ExMzZhMmVlNWEvdGFibGU6NGQwYjE0NjkwODIzNDNhZmIzZjEwMjBiZmE0MDM0ZjgvdGFibGVyYW5nZTo0ZDBiMTQ2OTA4MjM0M2FmYjNmMTAyMGJmYTQwMzRmOF8xLTEtMS0xLTExMDk0MQ_82215a1e-ac39-436f-bb56-ed624d889220">EXEL</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i17e417b11a954ed38a4e548f5772d460_D20230509-20230509"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhZTc2MzU5MGY2ZjRhNmY5NTdjNWYwMDU2MmVhMzdhL3NlYzozYWU3NjM1OTBmNmY0YTZmOTU3YzVmMDA1NjJlYTM3YV8xL2ZyYWc6NWU0MGI3MjMyOTVmNDhlYWIxZGY1M2ExMzZhMmVlNWEvdGFibGU6NGQwYjE0NjkwODIzNDNhZmIzZjEwMjBiZmE0MDM0ZjgvdGFibGVyYW5nZTo0ZDBiMTQ2OTA4MjM0M2FmYjNmMTAyMGJmYTQwMzRmOF8xLTItMS0xLTExMDk0MQ_22582716-7b12-498a-a05e-99111ddd3281">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="i17e417b11a954ed38a4e548f5772d460_D20230509-20230509"
      id="id3VybDovL2RvY3MudjEvZG9jOjNhZTc2MzU5MGY2ZjRhNmY5NTdjNWYwMDU2MmVhMzdhL3NlYzozYWU3NjM1OTBmNmY0YTZmOTU3YzVmMDA1NjJlYTM3YV8xL2ZyYWc6NWU0MGI3MjMyOTVmNDhlYWIxZGY1M2ExMzZhMmVlNWEvdGV4dHJlZ2lvbjo1ZTQwYjcyMzI5NWY0OGVhYjFkZjUzYTEzNmEyZWU1YV8xNTk1_20a564e4-7742-485d-93b3-2671364d6678">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M5LTO-XS"&-D7X/E*2G-LV -K\?^&X3]02P,$%     @ IH&I5I^@&_"Q @
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M\SR. !9GD*88 J<11S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$%     @
MIH&I5I>*NQS     $P(   L   !?<F5L<R\N<F5L<YV2N6[#, Q ?\70GC '
MT"&(,V7Q%@3Y 5:B#]@2!8I%G;^OVJ5QD L9>3T\$MP>:4#M.*2VBZD8_1!2
M:5K5N %(MB6/:<Z10J[4+!XUA]) 1-MC0[!:+#Y +AEFM[UD%J=SI%>(7->=
MI3W;+T]!;X"O.DQQ0FE(2S,.\,W2?S+W\PPU1>5*(Y5;&GC3Y?YVX$G1H2)8
M%II%R=.B':5_'<?VD-/IKV,BM'I;Z/EQ:%0*CMQC)8QQ8K3^-8+)#^Q^ %!+
M P04    " "F@:E6&445]3<!   G @  #P   'AL+W=O<FMB;V]K+GAM;(U1
MT6[", S\E2H?L!:T(0U17D#;D*8-C8GWT+K4(HDKQX6-KY_;JAK27O:4W-FZ
MW%T6%^+3@>B4?'D78FYJD6:>IK&HP=MX1PT$G53$WHI"/J:Q8;!EK '$NW2:
M9;/46PQFN1BUMIS> A(H!"DHV1%[A$O\G7<P.6/$ SJ4[]ST=P<F\1C0XQ7*
MW&0FB35=7HCQ2D&LVQ5,SN5F,@SVP(+%'WK7F?RTA]@S8@\?5HWD9I:I8(4<
MI=_H]:UZ/(,N#Z@5>D(GP&LK\,S4-AB.G8RF2&]B]#V,YU#BG/]3(U45%K"F
MHO409.B1P74&0ZRQB28)UD-N5G0&3K;V"%TH?653#@%%G=W4Q7/4 6_*P>-H
MK(0* Y1OJA65UY**+2?=T>M,[Q\FCUI&Z]Q*N??P2K8<<XY_M/P!4$L#!!0
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ML;S63AI_YHOA/UY_ 5!+ 0(4 Q0    ( *:!J58'04UB@0   +$    0
M          "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ IH&I
M5M2Z^@?N    *P(  !$              ( !KP   &1O8U!R;W!S+V-O<F4N
M>&UL4$L! A0#%     @ IH&I5IE<G",0!@  G"<  !,              ( !
MS $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " "F@:E6<X<G[D\$
M  ![$   &               @($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N
M>&UL4$L! A0#%     @ IH&I5I^@&_"Q @  X@P   T              ( !
MD@P  'AL+W-T>6QE<RYX;6Q02P$"% ,4    " "F@:E6EXJ[',     3 @
M"P              @ %N#P  7W)E;',O+G)E;'-02P$"% ,4    " "F@:E6
M&445]3<!   G @  #P              @ %7$   >&PO=V]R:V)O;VLN>&UL
M4$L! A0#%     @ IH&I5B0>FZ*M    ^ $  !H              ( !NQ$
M 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ IH&I5F60
M>9(9 0  SP,  !,              ( !H!(  %M#;VYT96YT7U1Y<&5S72YX
8;6Q02P4&      D "0 ^ @  ZA,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="exel-20230509.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exelixis.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="exel-20230509.htm">exel-20230509.htm</File>
    <File>exel-20230509.xsd</File>
    <File>exel-20230509_lab.xml</File>
    <File>exel-20230509_pre.xml</File>
    <File>exel20230331exhibit991.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>exel-20230509_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "exel-20230509.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 22
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "exel-20230509.htm"
     ]
    },
    "labelLink": {
     "local": [
      "exel-20230509_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "exel-20230509_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "exel-20230509.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "exel",
   "nsuri": "http://www.exelixis.com/20230509",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exel-20230509.htm",
      "contextRef": "i17e417b11a954ed38a4e548f5772d460_D20230509-20230509",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentPeriodEndDate",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover Page",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.exelixis.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exel-20230509.htm",
      "contextRef": "i17e417b11a954ed38a4e548f5772d460_D20230509-20230509",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentPeriodEndDate",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0000939767-23-000047-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000939767-23-000047-xbrl.zip
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MP(  ;U+F%5F4_>M1RH+T7RBO@^Y$GI/U/TF:S/U<\+#.%*S;&!-351B5#=
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MU%;;4BU_Y@?TI0:=UK!OM<XPI[EQ<C9IM-JB-3ON-2K'?:!;MOJ]R\YY3>Y
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M,LQR3M<LH9PE/ V):,CB-,-&AD-&HGDZ;B/_D,T<PE?/>#XZ?3UR0KHQOV(
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MVS1ON&K[[Q?K: 7['5^-?@-02P,$%     @ IH&I5M7=$&6JIP  A]@  !0
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M$1P#< 67-LD2UT?*I\=;.?\'/\)EENW/9AX>'J\Q!T*,&P&^Z<-?O[)/?8@
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M_Y44@'[P?K5U8:CX@%*0>\Y_)P)@9;J$,YQOK7#-"_\O)?SO+FI;[P!R"!2
MD );P/7\$KZ#1_B?^;<4;3[)R.8;0_C*\1_>:WQIH<H@^I@9(MV^\26EQ!3Y
MI\$B[6=]^)LBTC*GTL/3:$K4A;34N:SOD&<J,5R-3><H?*!B'7GEJDK'WCX^
MPR/[!PZ)U%A&/H<SQF16'2PZ?5X=BDFZ8+I0%#UK ZX(OE.8W"5M\3L5Q"IF
M@3,VUT5\REPPCC@21)H7KO;IE0 057N\Q6W9/?L:0\BF?)_,"B IG)37!=1<
M?B%9J*P7$1EYFG'AO'2#P3BIP;GOU%A(JS0/)Z\@GXQTW\V'JY*,"$E34QSP
M"7%\+M/ _(OQ?.U,T"G/>Y!J"'NNO(E7VL"1JG.^\ F:KA_5"/ZW.RA6_4Q(
M]8]&Q'.2/Y$3JM2'OT#+P>I3DVXH =T$])/Z2XHC=+QMA#9<'@P>%REVT\9&
M6>H$F&MJ*T7ZGP\,NK0D(D7M(E2+G7T2I7)!RMPT;E^H382>@#C7GK>N23&M
M##1D\#G)50]8!7FPNKP3#U$LS2,@XQ IO$]J$<XH$1YA0M._ )\4K: B]\PV
MV9"]R!B[8LC&3_,P$4LO^ZJ-GZ:98<CPS)7W2+6T+>#,=_V#3LQCMR_N/T;B
M/9F4$YGZ(>Z"LO:8X06:<TPCP$!X-3I2W4;30W,!BNNS>?4<3<9%3A:<35,2
M+Y7HU^(@>W&_%!T;:HC))\;E0$7YP<A"I@P?^H',"].7-,;:YG6KZ&$>#&9M
M.2R?7G!4OU9UHBF-84=L 2\4:<X;JN4%=-#*&GK.A4^^'Z;O%]8,SE"6B%TQ
M:,J[')]$=EEJ-K+BQ>&TM74AVD]11V\U]N7JY?@<P[V2WL>X_\-AY<ZBV%?[
MT]?BQ2+GKDC[P2=I*EP9WI[WK\]XL@68#BYR=U]>A5_QB>SW&RCW)%X6*)51
M] /G)4&;Y%H.U#K/1B[O-O4'?WE^&'TSQJCI^"NJ3U=/"Z\N+3N,V%AA;U)G
M9JQH'* XSFR)5 =DXN)A'F<).LH[*121TT)YJ _4JDN'=5>?(F--K8]_:\C^
M&5)F3HL%1?<('!DR?.SL)?6 K]KB?.BG+\HOCR*941>>YA_Y$GG)GW8*Z1A0
MS!0>^TJ8-UB,2F\%=CMB]-E%UM0GS/XM3LX1YK1G AK7W9EX9K,=).7WW:.D
M<WIQ2(S2$$%-1DWBAVYS6[[^TL7%.#2F4U5]=/^Y,%8.YS 26 DPG7&@+/)7
MSI1JD:>&Y$WZ,2^,>^M>?J48.<DH >^K]O//.:+/:\^5M' >L+M+3A=)*RGA
M-4!:185G&1-];9=6?L3K[  ^2ODDIH1\.L/A#XW2NT\8Z1*/>O+E?-1I\I7]
M1AWQAP:EH>97&22&C$W57BZ9K!Q5C@A)/$KSYKS<3'I3VFRFN>?MAMJK 3-:
M.QX_OWINJG#.@$GR:H24Y"1RTLDI1:?.^(P_*5UN<)JR1&B5LPF"YC&K3^YA
M],5]-$U7 [HX&G=96P*<!<G8F+_S<G:%YLT#D_7*$ZS5 3Q#)@W9)FU.'>)L
M$3]H+ZC;+B7&7/L2CR+7;3LV/,(7X.9ZDR6J@"PW!) H8I5IE)O9WR3 >:O:
MW^O;0'6YW]13!*=4Q"HO^\F;,8;*\GY3 _W$IO,-MW=BLUWR_IZ#Y$V2%_=I
M'-]C76\B9,%WZ&'&Q\PF(#PB::'^Z4 ?];Z7W#GAM))J9X%!/4T_^G[UQ\ZA
MLI%7 CK%66_%S-\;;$3Z'-$*+&0B S-'JRI6M]%!5\G059\TZ(,].M6&S!4V
MS TE="P85.Q^0L,2F#0'236V79/0+S"?KJBS(TE)5F7G&$7B$SU<%[BC-.!Z
MK*-%XIW,)X0TT=SU],%"/I'K% 9@6/;%@Z'5]JL$<W)F =15R]AZ2H%].K8D
M.8INC[AQEU[PB@?%ZUR=!WO[T/ZR,S">9?HA)OBW+KO<<E.OC 'MJFA?E@E1
ML#HBA&+HYZ%]":LUA[^-;A*@Z?\K1;EIB^&YYM]Q11%]Q)&V@AG8KPGA3-:Y
ML04T[8N_/J#;T%Q?<^92HZV)PW*F0.1<N.<5O7YR%'18G@M0Z.$(9Q\>=&48
M%*)]J[N(H'EX\S(2%REKW$8*YIYK^U<XE*TME&Y;,=H7S^Y-9IJCJU%X?K8(
MGULN?FDYF>RY27L)F([WO50&3;'Q(68 Q*"BKE $F&V**QN3<T:AA&QCRE)U
MD\(3\KG1\+!RA7\@%-@OMS_*PO5H8'59Y!PAO+ZR]H/A9:'K<0',IOBC'MDT
M<WLOFW(^O&ZA&VS0),@193KU<7_&YP_:M2Y=HRV2Y./'S/<_RN8S$SD")O2&
ME_:URM?3#C%8,2E>]&F!=S$%2$AX]K$7R3MYU0^<J881LMA.]:D?PR#CSYJG
MA/).H\2W2ZQR/QI^Y_KX5'E8:/(ODK:K3)@KU.P@EEJPU<2JKFWC3K5R9TO'
M../^Q;VH2]K>43FF4\UC_*ZK%,=KSUJAC4B/"XAP$5DIRE]#WH9/PN&#XDX(
M9?)+6T!E;W?+3;C_Q0 $9[+>C2;JU+'^+:!:\$)=6 R:RV;I[AKCK83-O220
MDJ,=GQ*XJ_VL4=]Y#Y08B6CDL<5>6S'CEU5L"58K%OZ&>9^^/SU%ZW#":\Z[
M#4&,@0L/+I7=\]5[(66SC"MT]F5P7_?*/(ZL6&.FD*(AG!>&-=41UR2PG37)
MP_5"ED>G[^QYJJ5;=%(?=>P0UXM6VJB5UF:!#G6-T.(]S)LL]H:1ET[3+_7Q
MDM0P/MQ@M C7$TK4)2490Y'A7*)F#U71FQ@C'5MS::\B3O$NU3Y;(XFX>)IQ
MD6%?BY;8$2%60>%@AJ$2B%8#?TO:E<_N)T@"( P,WRF,TL[,I9RZ#J6[+FV^
M8IP+>'7>VP*>W=TXVU%,-S^20@+9>RA.>-UT[-%J]4P?MU/7HOI^2UU9(U,R
M"47^R-.?NRQDI'.M=0.L48D]L07LDZP7)6E$#+UZTK':6E47?"4?<#K+,S?V
M3DB2YTXQ(FPSQ8.JX\BJ,3FUN;$O!5DF1?OLBLH17D\'+E13^?VH-D26[Z)@
MX^233W\0T,Q1]/^!GE@EVT>R)@_"]8A!DV,$!+.6+HGUS /GI_I:$B'T,8-:
M!R0S7<RA-9)XYV=/5<X'G<7&: 0M'(TD9;6FN]/(_&R"LB3*UMOPNHO9FUG\
M6+NQ4"N_=L3)OEX3L3W,#KE:GP^44#PC/%5H.DT 0"B4#=TL*N(,KU?4\L-T
MO>IB1\ A@X9#JU_A F)OCWHRL0=GBFG&5@8T-A0Y<XS?QC+=1K]LF!;#&IM]
M%'[J<J"!WD'K\.GD(S=47B9:E'Z8EF+UY]!/U'5EPF3#WX;[-P[FIL:&/QL]
MAZ932E\=EO",SQY4?!6?-2A<V4-]\3G'^*W;^FT2DH5.J9EY5>87&LD0J:C7
M1M%OKF2I!2O$+HN),!RD6)NO.YUFV,2YJ.[G'+L<MA!*Y@V]..:%OWC'[*9'
M!GM1Q%MU_Q:D9SS,#^@7KNP6QJ;RX+*]? 05^2@N?IIU9J<5H3AV W& Y\.3
MVG:A5C+;2WZ3L9?JV4LU')?&:AA1"B/;69.0?NKK&[8 I_X%NM7B,-,.+I\#
M'OURKTH(E[(ST;4FG(ED#)R)NL%9-"7LM_5VFTH\;Z_ [DCC(A5;#[SDWG/V
MA>GP]'S5RTLQ&[;"HI)//>283DT_Y2'1TM5*TO)_;D+(<GQPQDM. &_]B8<4
M[)NO>D..C#(&,-T4-BH3X)R+KWS5QM<+KA\,WW\^ADT[]%@_YN(E?\:O3,PY
M% 7 \]E*PO"L24#UZEVI *,\>>G9W05P\GI^[+#-?.1AAN@RLWTQ'EEBJ_!1
M1O==3^0];GC]5N 1</RL(DE$0\+58>,+54UA)Y:#69*DZ/91>CYV EGI(R;W
MEUV"KPK\PGA'1?INJ_N%XT2C9FJ>JL>O%<4NUP3J:B5:'2MDSS;BD3@'Z:.&
M?=:]?=3S5H6\M]?'@2?5Y_SA4S3O6>EJKYX+ 6CZ8)Y,N$A=5Q#%_BO%OK@K
MBIWR"M=OSWDTS%QZ?_5*[%V.0UDJ!M'7LDRM0P%2ZE-'EY;M)YB$SR':JR'/
MPB=A=1>X?*G:KD;78B/>Z8R:2'-O:ZG$/(58>AY\W?Z>=M'9LSB2(=;E41.)
M"=-IY&=?BGC"#&](S5//HTI]NDM<"=FF,9_IY0N3G"-3<AUEQ*6+, I-(,M6
M]PBP\4_XY4F3>SV%LEV0VR0_W26,;_,8EEL%GW0F<:>'7^>0.WREN>:6$G6+
M=7B^?&I6^>'A0VWG\0$#&B<I(.<SV%"<#?5T"O'5Y3IC ^QW\5Z7WX2GL;G*
MO>-1'KMU^RC[+^@SNU'3?HAWGX-"EK#FOK93)!?A$HGH1T\2,.JDEQ@@D$Z!
MQ'CVNQ2ZBF2+,[ VOAD-<)F[RJ,L0?M;]WZQX(Y0'Y(H5-2Y$'LYA&WC-CBA
MM;:ZV("]AIKV#<LV0M#TZ<<K$B7H@!%6+=D:G]VO_OZS$>X++1X,MU&9*^=F
M]3YQ-I./C4J("9#VMC+8O,#1/3U QA<,2USVM6C.*[;5FB&CHSS\V1B*Q( #
MF&FO1Z8<#ISKVW=Z,4LH$66AKA=>WP0]/RH3U;#^Z#MB:<SC!MQA:=F3E]#[
MK&0AL%CU4= _5_S^86H=."=YN<PL8H5$'EQ%Q/>/R"M<L?O'R;0E^$S[[SBY
M94(*L<6?F[[JK/P1X.U<?[MI^C(A<U&)7U6EX[PJCZA2:QU%S!L!<]KE\,EZ
M/PBD1;!%?2,8F+^_CUH915QT.('+%\)R"7??05(U3Z&>,/ T-1]?"HRY]NT@
M$\6$^S*R@-)78BU3/>*M (G9H2-J6'\Z&8HK0ZD^A)Q=_M*D[S HC_72)&&J
M][S];%!8UR-[U.:Q<XB9SYG*QMM?LB^=B#O?+EFM=8$P]<VKDZB[+,Y8GWEA
MAOJVH'^%$*(V68-/Z)2R:)K!C)LE%AD=?[=,$W</4FL^$>[!"F:;?8R=*;G/
MCCRI.N?=$N7%A$A(X,[71AN(Y.A>]M[H7PJHQ7Y;$>#3S-09%?+8!SI1(%W_
M8^/=.L*>X"];!+ *885Y&$)W,?5&D@=V"(K]&Y\Q</V)!<\"I0(\XY]4_P,>
MK-I0E6DR:P42B%#9SQVF/J6H',@PZI3LR?#E7WD@R_KZAJ3B>-B"EM\6\(8!
M7)=HZ:*;$#K'SS=O/__$(U#A Q2D91PUVN$Q &1S]"9#;"&;K@M>G>9=R"VH
MS!8PUA]6S<>\_]@9]*K[DD80XW7Z4%&N ]5&G8H,B ^/I3O7&  &M#8U(P]+
M @??TWO"=6:7OO,;FX2L2AT4?B^=EX$,+-TSJ=]ZO5:)4I'1*2>RY#,F)+)3
MBWNN)I?)<;FA+ZU=\D%:HY;NINP60%S/0';6,Z52#UKP58S7C*-O\#I^I^0%
MJ"Q=DPW:G?+O\)J$D')#L^BRS$ZQB<HDF%X?.=5OUM')8VH><M8B.4G,G$3I
MS''!JJCUV(%J"$"?X)ITS3#V[EX:B&KM:T>'HPD,]RX?M<CKE"TROYK ;^P4
MU7)%*-(7&F29.Z^CB^&J"-*X=WS"XD;2T%,E?X>O["VQ)3KH3_<,YT"O&#O=
MM*F=/9@T4BJ[E.<K(MMJA0CUZ<M*PW_LFM/Y3A70J) Q4OY0Y;3-W'M.5PH*
M\45W[QQ-I;;-)P^\C@=)=+3A;"T>SNKXO;":"/052]C3W=7;C?B4<=<9[7&1
MZIA+H5/[>\5('YL\#T^Q9"D^OH.&E(\>IA[IU%?>5^:N?0VULAIHF]LI;5N@
M2'JAD)13@B<K;C/:.'RF)":=@T^1:Z^Z%L#5CM5,O(CAK/7/43.>NR-YXY1C
MKJ]1X@&'$\,M-6JWHN,Q\GN%/GB)F3Y^;W_W=$6ESKP/]O+(YV'V5\]:Y']I
MOBLV-3SPI(7!YR#CK1/)*._SUR/]_?EF4G8X!3YXOA0X?/=#ALE!AJ*KWL4S
M54R/1L7,7UCYUAQ=DGH5^LL#1/OM&QKZ'U=:F?)Q" A'TIIIWMO,,,=FXK4'
MWS_2'/SWU-EM3C.'=O5J2]G3K.S7.WBO_ YVHI#09,:>7B%\M@"=FUO/IVY%
M9ZIW]?+EQP8W8\- 46P=8FQEQHO3%(M*;N8W'*S?O?XTG7BPZ8-3/KM2Q:GG
M7^:T^_,40F,>WI#(1L@<?2Y]352]=+S-/C@S)2-FXTW+>H<G51XN_YVU#BK*
MCB+&WEZ&1-0CWU16!X$.=#1/OLF_#R%GF%!\;X^5WMV. NU%JGPF9L34Q/"Q
M,%#U'D[+4Z+F-^>[^ULRNI(65B:8CKM*O^P.O-_F%D(]PC=(%^Y<?X3^A3ES
MR]DYJVJ[F'@CWM5K]QN2$]YG[;L/?V%U+[- )_,DL]V%QSGTWTU=$;3EFE-<
MG?8FE+,BUBO<1]<FJL[/V_A:J*TS"L[$B#N_BTA\N>^0UW!HC$7;["=.QID'
M>MT/W%\X^W5.%_HL,MV;;;GN5UJT>1@9Z.NC$V]ZC3XV\@+%VE#.A*#-@9?I
MEV-"C8;P\<T?\_>)OLL[?%7@=MRG],\&U,EWX(I>.@\W=%F?K);F=*9%A+_P
MM8P\6FPY&2*]!40/WQE-,KMM(+LY/T%Z(A0<(R=HTS_$."Q:9Y-E+J:D].2%
M45V^<*F"JFYQW[ESQ\J3[#HWWUMGWN*P2'19O7<[=NKM=,[1<K73>VQ+48I&
M.B'):4[O<XX@) S&2LPX&TQNM)"J?L;N^70H8_B5>=9Z;R]V<^P+0,GZ#E71
MV'N\B8N+BY&;O3%@=KAUHN&);EYC9Y+%-9DS<7E),105KU-KE?P?XE)&?8KC
M7CQV)6%^<8?1-Y[YB^)=<$4G6M$U;\R8<KFYQR?!J<4LOL"8+[?E@D*.X!.^
M>B37PA2/^DB PJK;%K#W>>WC.!%>>]03P[T0A8FC3.>[C4=$CE?@[)EO=U3W
MGDS)XLH4V"^D;6!4PV:D=^AIHGFEU(T3AII9=N4=]^L"9@,V6A.6^N3^^'\C
MZW1RH,4C.[T0G?9KY:8OO"J>2]^_*=695\B\9SC/TF\@_R%GT)6')[*>:[S.
M4YD?NY2SW,%F+-U3.9&BQ_A*_/I#![HO9>)<55BN-?B'/_T_CSQ5HG3A[O&'
M\3'%U[LZAY>)/BE<429T]I?*H\[H-DOA*.P0;]M1BTUW#3NC)(:2GJIR4H/A
ML8J*4O(R!NB%A^8^\<.'HNI$_-=\%MHWQ:]WZ3RL.:RC]>B9=C>SG7[EGE&,
MQ[V1]]6VY0?7Q%DD.Q?&[L>WW'K9C?7/9OY@F]FAZ;"AG)RU./&E@"G0ZA-,
MX(A()R77'=7CZ06F<+="R]:C#S>&FCO/.AXY$;X*U<2D\<G]\69L8*CGDSSC
M63#@?H/:.K;],M-]Z3TTJ5\B.^QSKV7O.7O?@-E6,U=ZX96%VV$S,TOK[H*4
MP0XAYLB$F3#^XH5O.KIVN5N NI[G DG$X)]N+RY=RGTPMYH<7,?&M-1\;'$+
M$"2&33F9X=G4-D51UYPHVVST9J!VCMG+03E18VD69K,[R9G&6L)Z]C^=$]W[
MX+U2'NZVI79N1;]GW;WWS-^.C7N<.TH_F_0E3]7W;)YJ2GPRBM^J+/F%;H:.
M*GE.MH54?O?RFD\YA?,@ZCZW(HY^)+CXTOG3J>]5#-)IQ(\SSYH*R)P__XBD
MYF#K4ARW8=W-9:K)LNN:*A (M<?J%R.MD68PV?L5%=T4S[(O#34K[!P15.2\
M]EST]AS;,?<GZPG-G6Y3KN5Y.:VSZ6K!^&G'.7]VUO5;K69\%JO10@<%A'B%
M/P_/+[MUG<I4R+OFJHUR^<+74FYA<2J^-3SVB0:Z>=/W ,IRQ:ZN/RX[;#;8
M_=23UT*3TD4XNKB<Y$/4I-"V.<L$;BWFK/W!>_X7:6\9%5>S;@LWP1(<@@>W
MX.X6".[N[NZNP=W=79K&W26XNT,37!H+#H&0CW>?O??9XYR[[_GNO3_6^M&U
MNJK6K&?.9S[5-4:;/8_$EQE,O$ _H)#EZ)6VB<Y6#* #F#5S)T)$*G?:C6=
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MGK)\IN&0WU<+W=_&-FU-KAV^GD"81LID/1&D[.<^=A43Y1,E$\>PJZHBJ5$
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MZM"20OCO2$8KW;#-4\S8M<@,[BE=U(A/:(1)2<6<Y!/G]]=UZ)\QXF)#Y(*
M"UUZ(CEVUS%IHC+WG]VQ,$F4S\MB8G1FC$-;,SD%'4C?G^5?U?['":EW<%\
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M797N*&9P5]D9P],ZFU=\Y>VKW9-$F%9[Q23(-,.I>B:/<(D'CTC6;/9SYFP
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MY0DAS!;EK1VA&?_!2V,HMFLQEN-['F+21F@>B-COD08!<Q".LU;&8+(5U<+
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M7'TNL7NV=5:\EC<]*_EU^5 .*9G6^GEV@O^>XV04  8 A#)\U\>*C]@FPZ<
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MWPT$*Q]"NPM<)1[P1& S'^FN;G2X3>ZP!;WB0KK7-7@F.8SEA=0ML[L*8=(
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MKX**8=7P P!6<F(B\DMN2PL2"B+2P=AI5IID) .E$?,+:3O@I 8.#AQ0\Q^
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M*)&[VU4C#L?4(7"# ZTD^(4H4[^GQ41)2\>J"%@)-(1*TB(1=R<5@L:06A2
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M92C51(-SBR0TDPESMP@?S*L?N_+V3Y+]BUL]F_QC-I7'5*&XO;)./_3J5"S
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MM&1WR[T0-:%ARIS'>(4W*#TZE^];S#'X3H NSD^!9$!3'#[]'W9QUP(<]85
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M.S'FP7*^,II61\N:&#P"XRJ>[_L#L/S_7^OF&=54M^W]($VJJ(0.(B"]-R&
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M H>#@O&-N;1._=Z;X^4->9T3^:F8Z^KK.P.]/&LV0,U<2!KEDP4 '=[@2%J
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MR-WE[O(4AA8WV%FIV5F'\N&_,B"V)H8PQ1@\K56?73GX&I6GIV8,M4OL8"F
M/0"7)$BFQT["4UY&'P)25< ^U*&P)*D=AP6@7,WP/Y3FA"Y1KKN'J3AM\ZP^
MY00Q5VZ(;#TBJG378WQ3[MO0KFX[4\Q#PPCCJ^$8S #\&O"6?77@RT>1Y8F(
M#:;_ [HM3,Z7_0.;IX^#9SZG<*PH?>"OTP]W:IENY'G1,MWTC12'1N^9.?=
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MQ3_;"XS27O+J#N,W/X;TKI(U#'[*KJ=-%6LHR/40VFD9;.X/;2EJN1W#$MP
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M2T11*SY?'BUL*XU.5I/+V&HV&K4/M+C7C5NG==V'*ZTJ@VSW[13I7NJXJ@;
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M/3]ED:O$M&*&G>:AHRDLR2]Y?IG\FID@<UIZ7<R:D1T[/P&E.BGP$4GHQ0(
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M'*8^]#+2HUQTLJ='Z=@=?^ RTBG9S9+2[6/NY:6^97'RY;K(EQ.^*,9*2J1
M"E,($$(IH%IAH!(2:QI&G+#.][VL!S^VPM'H"QJ!SC/E&\;M+P9][#@P^0Y.
M. &^+64OFC>"#8;NMC16.=W:IN>@_DLQJ]CD/]G-_%0O"(\Y# $)0S.N3\S@
MGA (08A3A**0,)U2KW%]JYMC W5]X#H7&QBU7F=UJ[.. WQOOP8>XW>URG^8
M;W6B_TB_'?;G#/:MJ6T=[]M;N^/_O<RJ2N7US-YMOKBI;39&1,0)H1Q()BE
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M 1&2 2D,RC31, ZQYY8!?Z7- IYEEX!>^P/\178&./B6  ?:#. 8M@%PVP#
MY:?_J]_$N7EV^F+Y2C;?>_STQ?\!4$L#!!0    ( *:!J59]5*)^K@8  .@P
M   5    97AE;"TR,#(S,#4P.5]P<F4N>&ULS5I=;]NX$GW/K_#UOE[&)$52
M8M!DD>MM+X*;W09M%EWLB\"/H2U4E@Q*:9Q_?T=*LLU7=X7(0)0'6Y9&FN&9
MH^'AA.]^WFW*V3>(35%7QW-V2.<SJ%SMBVIU//_]\@/)YC^?'!R\^Q<A?_SG
MT_GLE]I=;:!J9\L(I@4_NR[:]>R+A^;K+,1Z,_M2QZ_%-T/(27_3LM[>Q&*U
M;F><\N3IU7B4Z1242( ("QH_5"#&""!629#,6^,Y^_?J*  57G-+,AG0++,I
M,98I(G2F 9*494KU#RV+ZNM1]V%- S,<7-7T/X_GZ[;='BT6U]?7ASL;R\,Z
MKA:<TF1Q;SV_,]\]L[].>FNFM5[T5_\R;8J7#/&Q;/''K^>?W1HVAA15TYK*
M=0Z:XJCI3Y[7SK0]YO\8U^R'%MTO<F]&NE.$<9*PPUWCYR<'L]DM'+$NX1.$
M6??]^Z>S1RYA!V6Q*YI#5V\6G<%B62,=+LRJ"[>_O;W9PO&\*3;;\J]SZPCA
M>-[=3+J\4DEUY_2G[S<OOOO?1FB0,OUXS_'$W3,Z;Z^+!78M5!YNQWCOI:S=
M(Z.R0[B.]W>6QD+9G\T]%'G_Y%/;M-&X-K>2"<,")<HY242PAF1*(I3.>BI2
MG2:I>#ST+NP&X^X3TH [7-7?%OA@3 SGW4&'"^\Q>>;N%IO7Q7V*+Y_O7L /
MI5GE-J26:<&)38PGPF2,9&F*1XF&D'+ %\B-BON1N\=Q/\SJ:72S.GJ(6$+N
M_9GHGF7X,7WO+!9;$_%!Q*V+TM_?W=62?62KK?>!W6UF,-[Y#(<=($;PY[>)
M^>'H^J&U6%FAMQR3]/NB>P&QJ/W[RO^"I3?WS&NJL0AR$)0(! 5+IW98(E-%
M&0!UQH]*_HMN!Y& 3Y<$X[%\8S*\K]JBO?D$JZ)#HFI_,QO(,Y\:T#@'>I7@
M_"A8(!H!( $2RY447EDYB@LO>1U$A62Z5!B-Y"28L$2LHBG/<$+<_0]N<A.4
MH]2@0 H>!1*%C!C/)(X"0=$I]T'O@PI/W [B@I@Z%\9@.0DRO-] 7*%V_V^L
MK]OULMYL3763.V=-9BFBP"'!ZN84,;Q3VEH!38)+,N![H,2+S@<10TZ=&.-Q
M?6-Z? 9W%7$@C-O+HBTAUX8RQ[IY3G>Q"Q^(Y=P0BZ-(198D3+)1G'CJ<1 1
MU'2), K!-\[^933=BO[SS<;696X$-ZF4ED#637%*.&*-R0BNN(U0D()QXU8-
MC]P-RGLZW;R_'KN)O/+O=VYMJA7T\@8$4S+50&30HB-M1BPN@%#W*HD(!0.6
M[N6U?^AU$ 6RZ5)@-)*3T 8?BA)^N]I8B+E0*<4A9X2&)".">2 V!$]2IXQW
M$I>_VNQ!$'SW.(@!>KH,&(7@)+)_5KDZ;NO8@_X9L8=E?85J]V99>\BIX51F
MU)%@>4H$2" :_XA B1-T2'BPL ="_&T0P]I+=.HDV1_0D^#-I=F=>82O",5M
MQ_KN!?!@@Y.I1\6+<Z#P',N?,))XP0-#I)Q+Q^G'OW4_C"L3[D7N#]Q)L.34
M>\Q!<_=U7E3 <J>=$C(-)-44J8[:F!B;I$2C:$:=C-.GT'M@R NNA[%CPDW*
M_8 Z)68L\?!CO*ROJYQR T*DCB@3&!%)T,0(*H@/5'+E5"*2<1+T!XZ'L6+R
M_<IQ@$Z)$_WD^#%>Q/I;43G(F4E\)ET@RAK6*6I.+%9!XJ24+K. %%?[(\83
M[\/8,?D.YAZ@G1)%+NJF->6?Q;873\I0*A.&X@DA0O$D%-$)"T1P956B>2+L
M/C3'2[Z'T6/R?<S1L+XQ.;JJ=QK!]'$C%!D+6/<$]]VF$"Q^FB&I/4UL)BB$
M$,8)C(?>AA%@POW+5T/WQBGO=LJ4%^NZNE]Z4RLR+%N"<*$LUK(L(QGS&6$.
M %0&B$LR*NU//0Y+_81;F*,@?./T?XE%VT*UK#>;J^INE=3DJ4JL ]2]4H,G
M0FM+C ^6, K.<"ZUS\9MV'G1[3 B3+B1.1[,M^YIUV7ABK:H5K^BP(F%*7,;
M4/P&XTG6]=^$-H%8JU ,NY R2)TWW([K:#_S.8P'$VYGCH3QC4EP$:%C,*"P
M[7;R7'9[ >/'@''D&4VD1ZU+E)==6U8F) ,MB=+*X@4#4J>CR/!CW\,V1DVX
M?;DG6*=%CK.FN8+X<"PB<4AUYTC"N[G/:4\L3R6A"1..<IL&/FXSQ#]%,(PH
M$^Y=[A7BB6RMO$3;W*B@4B\1AD12!(0JDJ7,(LVUM%@>16K&_1?DH;=A-)AP
MD_+5T.TMY>\6S[ [QQ,G!W<7NH]N:_S)P?\!4$L#!!0    ( *:!J59/2.;L
MO"\  %[= 0 :    97AE;#(P,C,P,S,Q97AH:6)I=#DY,2YH=&WM/6MWXL:2
MW_=7]$YRLYYS! /B;2<YQX,]N=X=/^[8N<GNEQPA-="QD(@>V.37;U5UZP7"
M!AO; BOGWK$-K59W=55UO>O'_SRY[-_\[]4I&P<3FUW]^OGK69]]J'SZ]%NC
M_^G3R<T)^^?-^5?6K-;J[,8S'%\$PG4,^].GTXL/[,,X"*:'GS[=W=U5[QI5
MUQM]NOGV":=J?K)=U^=5*[ ^_/PC?@+_<L/Z^3]^_,]*A9VX9CCA3L!,CQL!
MMUCH"V?$?K.X?\LJ%36J[T[GGAB- Z;7] ;[S?5NQ<R0WP<BL/G/T3P_?I)_
M__B)7O+CP+7F/_]HB1D3UD\?!-<[@\ZP5Z_UZMUFM]7LU@VCPTVK;35[9K/9
M^*,.B_P$P^4S?C"W^4\?)L*IC#F^_["C3X.C.V$%X\-ZK?:/#YEQ ;\/*H8M
M1LXAK1:^';I. *OP8%;YZ]+DZS^TO"[#&\'2 G=ZV)OB@V(R8H8=_/2!WW-;
MW O_#]L=N??>:'"/@*O^.1U]8+YG/C) SJYVW.Q,[X_4FP9N$+B3PQ; 8,:]
M0)B&K99.NY!?1^#IP(-YT%RQX>AKT[5=[_"[&OUWA-]4AL9$V//#_^K#4P-/
M_)?F _Y5?.Z)H1S@B[_Y8;T.RY)_XDR'(H#AIOSD3IT>S&@+AT>G6=?Q"/LP
MPC #_X?O6MVC3<_I-9;=S%_VV!,^N^:.P[U=6K7@0_9%.(9C"L-FE\.A,'=I
M Z>*<C1VYIC5W5EWNU6K=!N=2D=OUIZ]ZO; :+_"JH]H/18W7<_ Z^8P="SN
MX:@//YL^8?X/W[6;1Q$WJYKN9 N,MLC'>!W"?.R?X6!@>-;N+/OTWU<:NPH'
M,)H=#X>&\'SVPW>-[A%0T8S[@>NQ;]RF0_9W:%<[S@NZ]5YS'WB!/Y;T\"1F
M8(+8R+U-N4'FJ2V>Y(.22H1O[-AQW- QN0\WJ><'[%^AX<%RI'B<7*[?N!_:
M@<\,QV)7GCL3(%:#,.U-$8:<_3JUX,?NP6A#^:[";MR H#'C3@@0<(?L^V:M
M6^TR>*\-N*2QOC%P_S:<0#ABP+Z ?F..A0\0JEY7V04/$'I6: ;9.1KM1K49
MS<$J.P627XZ/K]B)L$-4NDZOKFE#M6I=U]B%ZU16?=W>L6V";#_D'@=2@2.V
M;:*$W_C -(!H;ES+F#,C8"V2_&LU=G7.3N$;[CGL1DSX>GO],_0#,9QO2AS9
MQUZ+@QQ_/3X_/3E&A+?%L IW<%>OUX_8N3'_X;MZNW;4TXB)1#MXF;7EWTKL
MA5ZZ*=*\R=ZSH@0[N#!\R_B+$).=_G[Z]2,+"%T]#LP;B7(8<WE/<?DA"%'!
MF,,W>"7\I:X$(%RZ%1#SI_(.L. /%A+S9\"XX-,1S.'#&^[@$F4&\#X^0S/,
M+9\S,[XNW,&?W P$B&L:,WQVQY&>?!@PF7 /5Z(Q$W:&5@'Y-C'EN%-F =.T
MW2G9>0!F*.XYW%]+7BHH<>4?(A*37CNZ@3.(;^J &Q, $=XL(0 ^<!G()V8H
M(>^&'L%XZ@G7$X'@\JJ>&!9G/NQ#@&X,EU)R0L)AAC7#<X?3P:<3X+,!FLYP
M$$Z!WXT\]P['1>>@T?J V'U#6.Q<F&.#V^R\RLY=SQ.^S^<@HH^K)U7X 6\#
M1(%7XV129S^E=</Q1SJ[%N]2\A'8>O_X\^7YZ<W__@[,I-,\@IT()X#_P\X%
M8*@?&$'H(](@GMK<L'!]P=QS<>GL%E :+EWAC,5 H$H VP7>#7LS$==, S;J
MN!,#/U]"=(U9'BS.88,YO2NDF1!  Y@6)49V)X(Q<\3,M<.),<C,4B%$]7D
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M#$+/YQ/2B[GA.=R*#!@XJ3L<^IQ,=V. -NS5<^>&'<R724UB(X#93'M>W3!
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MSXA1**!A%7_?!;$3\>#L_*3_D7G"OV6^Z<K0]O[E]?E9O]*H-S98NY8J!8W
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MWT\K9WV9?P>N-8<?XV!B__S_4$L! A0#%     @ IH&I5N$^?8>)%0  0XD
M !$              ( !     &5X96PM,C R,S U,#DN:'1M4$L! A0#%
M  @ IH&I5E4=>$ML @  >P<  !$              ( !N!4  &5X96PM,C R
M,S U,#DN>'-D4$L! A0#%     @ IH&I5M7=$&6JIP  A]@  !0
M     ( !4Q@  &5X96PM,C R,S U,#E?9S$N:G!G4$L! A0#%     @ IH&I
M5HI"8])@"@  25X  !4              ( !+\   &5X96PM,C R,S U,#E?
M;&%B+GAM;%!+ 0(4 Q0    ( *:!J59]5*)^K@8  .@P   5
M  "  <+*  !E>&5L+3(P,C,P-3 Y7W!R92YX;6Q02P$"% ,4    " "F@:E6
M3TCF[+PO  !>W0$ &@              @ &CT0  97AE;#(P,C,P,S,Q97AH
A:6)I=#DY,2YH=&U02P4&      8 !@". 0  EP$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
